Next Article in Journal
Sirt1 and Sirt3 Activation Improved Cardiac Function of Diabetic Rats via Modulation of Mitochondrial Function
Next Article in Special Issue
Nicotinamide Supplementation Improves Oocyte Quality and Offspring Development by Modulating Mitochondrial Function in an Aged Caenorhabditis elegans Model
Previous Article in Journal
Improving Reproductive Performance and Health of Mammals Using Honeybee Products
Previous Article in Special Issue
Modulation of Human Sperm Mitochondrial Respiration Efficiency by Plant Polyphenols
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Mitochondrial Dysfunction and Oxidative Stress Caused by Cryopreservation in Reproductive Cells

by
Roberto Gualtieri
1,*,
Guruprasad Kalthur
2,
Vincenza Barbato
1,
Maddalena Di Nardo
1,
Satish Kumar Adiga
2,3 and
Riccardo Talevi
1
1
Department of Biology, University of Naples “Federico II”, Complesso Universitario di Monte S. Angelo, Via Cinthia, 80126 Naples, Italy
2
Department of Clinical Embryology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576 104, India
3
Centre for Fertility Preservation, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576 104, India
*
Author to whom correspondence should be addressed.
Antioxidants 2021, 10(3), 337; https://doi.org/10.3390/antiox10030337
Submission received: 3 February 2021 / Revised: 19 February 2021 / Accepted: 20 February 2021 / Published: 24 February 2021
(This article belongs to the Special Issue Mitochondria Biology in Reproductive Function)

Abstract

:
Mitochondria, fundamental organelles in cell metabolism, and ATP synthesis are responsible for generating reactive oxygen species (ROS), calcium homeostasis, and cell death. Mitochondria produce most ROS, and when levels exceed the antioxidant defenses, oxidative stress (OS) is generated. These changes may eventually impair the electron transport chain, resulting in decreased ATP synthesis, increased ROS production, altered mitochondrial membrane permeability, and disruption of calcium homeostasis. Mitochondria play a key role in the gamete competence to facilitate normal embryo development. However, iatrogenic factors in assisted reproductive technologies (ART) may affect their functional competence, leading to an abnormal reproductive outcome. Cryopreservation, a fundamental technology in ART, may compromise mitochondrial function leading to elevated intracellular OS that decreases sperm and oocytes’ competence and the dynamics of fertilization and embryo development. This article aims to review the role played by mitochondria and ROS in sperm and oocyte function and the close, biunivocal relationships between mitochondrial damage and ROS generation during cryopreservation of gametes and gonadal tissues in different species. Based on current literature, we propose tentative hypothesis of mechanisms involved in cryopreservation-associated mitochondrial dysfunction in gametes, and discuss the role played by antioxidants and other agents to retain the competence of cryopreserved reproductive cells and tissues.

1. Introduction

Historically, the first attempts to expose eukaryotic cells to low temperatures were performed on sperm by Spallanzani [1] but the first successful results on sperm cryopreservation had to wait till 1949 when Polge et al. [2] accidentally discovered the beneficial properties of glycerol as a cryoprotectant. Presently, cryopreservation of reproductive cells has become a necessary adjunct in human and animal assisted reproduction. It represents an invaluable tool for fertility preservation, gamete donation, preimplantation genetic diagnosis, reduction of multiple pregnancies, increase of cumulative pregnancy rates, as well as animal breeding and safeguarding germ plasm of endangered species. Successful species and cell-specific procedures for cryopreservation of sperm, oocytes, embryos, and gonadal tissue have been refined over the years. However, the viability and competence of reproductive cells are correlated with the quality and species of gametes and embryos, and with the extent of mitochondrial damage and oxidative stress (OS) induced by cryopreservation.
The primary reactive oxygen species (ROS) produced by cells are superoxide ions (O2•−), hydroxyl radicals (OH) and hydrogen peroxide (H2O2). Different organelles and enzymes are involved in intracellular ROS production. Mitochondria are considered to be the major ROS producers in cells, even though several other organelles and enzymes contribute to such function [3]. The two major sources of intracellular ROS are plasma membrane NADPH oxidase and mitochondrial respiratory chain enzyme complexes. In addition, other enzymes in the cytosol, endoplasmic reticulum, and peroxisomes contribute to ROS production [4]. Although the exact contribution of mitochondria to total ROS production in different cells is still not completely understood, mitochondrial ROS are thought to regulate ROS production by non-mitochondrial sources [5].
Physiologically produced ROS at low levels by reproductive cells are essential in redox signaling, which is involved in sperm motility, capacitation, acrosome reaction, hyperactivation, transient sperm-oviduct adhesion, [6,7,8,9,10], and in oocyte maturation, fertilization, and embryo development [11,12,13,14,15,16,17]. However, when the ROS production greatly overwhelms the cell’s antioxidants defense system, a status of OS arises which can in turn affect the structure and function of proteins, lipids, and DNA, damaging the cell activity or leading to cell death. Helmut Sies first formulated the concept of OS in 1985 [18] as “a disturbance in the prooxidant-antioxidant balance in favor of the former” and then, after years of research on the physiological role of ROS in redox signaling, reformulated it as “an imbalance between oxidants and antioxidants in favor of the oxidants, leading to a disruption of redox signaling and control and/or molecular damage” [19]. Recently, the terms “oxidative eustress” and “oxidative distress” were introduced to more appropriately distinguish a mild OS that controls redox signaling in health (eustress) from a more intense OS that compromises redox signaling, damages biomolecules, and may lead to pathologies (distress) [20].
This manuscript aims to review the close and biunivocal relationships between mitochondrial damage and ROS generation during cryopreservation of gametes and gonadal tissues in different species. Here we investigated the role of mitochondria in the physiology of gametes and discussed how cryopreservation-induced mitochondrial dysfunction may impair their ability to fertilize and support embryo development. Furthermore, we emphasized the role played by mitochondrial antioxidants and other treatments to avoid such damage and to retain the competence of cryopreserved reproductive cells and tissues.

2. Mitochondria and ROS Production

Mitochondria have a pivotal role in the metabolism of nutrients and the consequent production of energy through the synthesis of adenosine triphosphate (ATP), and are responsible for ROS generation, homeostasis of calcium ions (Ca2+), and cell necrosis and apoptosis. They are delimitated by two membranes separated by an intermembrane space: an outer mitochondrial membrane (OMM) which is more permeable due to the presence of porins, and an inner mitochondrial membrane (IMM) representing the site of the electron transport chain (ETC), and oxidative phosphorylation (OXPHOS) which encloses the mitochondrial matrix [21]. The respiratory chain consists of five multi-protein complexes, from I to V, formed by at least 80 proteins, 13 of which are expressed by the mitochondrial genome. Complex I to IV constitute the ETC and the electrons transported along them finally reduce molecular oxygen (O2) to water. The electron transfer along the ETC is coupled with a transfer of protons in the intermembrane space through complex I, III, and IV, establishing an electrochemical gradient that enables the synthesis of ATP through complex V, the ATP synthase [22]. However, even under physiological conditions, the ETC leaks electrons leading to the univalent reduction of O2 to O2•−. About 0.4–4% of the O2 consumed by mitochondria is transformed into O2− and then quickly dismutated by mitochondrial superoxide dismutase (SOD) into H2O2 [23]. Although complex I and III of the ETC have been classically considered to be the main sites of ROS production, recent studies demonstrated the presence of 12 sites associated with substrate catabolism and ETC that participate in H2O2 generation in mitochondria [20]. Specific sites acting as potential ROS sources depend on the species, tissue type, nature of substrate being oxidized, environmental O2 tension, the concentration of NADH electron donors, mitochondrial membrane potential (ΔΨm), and pH gradient [24,25,26,27].
Powerful scavenging systems for O2•− and H2O2 regulate their levels in mitochondria and the cytosol but when their production rises too high, an oxidative distress status is established and the molecular oxidative damage cannot be repaired, causing a wide spectrum of different pathologies [26]. Although O2•− has a high redox potential, it is not considered a strong oxidant because it does not permeate membranes and has a half-life of a few seconds. However, O2•− can be rapidly dismutated into the powerful membrane permeant oxidant H2O2 by SOD or transformed into more reactive secondary radical species. Even at physiological pH, a low concentration of O2•− can be protonated into the more damaging perhydroxyl radical (HO2) that oxidates polyunsaturated fatty acids. Moreover, O2•− can be transformed spontaneously into OH through the Haber–Weiss reaction or can generate the potent oxidant peroxynitrite (ONOO) through its interaction with nitric oxide (NO) [28]. Among ROS, OH is considered the most powerful oxidant, and it can oxidate guanine into 8-oxoguanine, polyunsaturated fatty acids, amino acid residues of proteins or DNA bases and deoxyribose [28].
Under physiological conditions, i.e., during eustress, H2O2 is considered to be the major ROS involved in redox regulation. However, supraphysiological H2O2 concentrations damage biomolecules leading to oxidative distress [20]. Although H2O2 easily crosses the cell membranes, it reacts poorly with biomolecules and the most damaging effects of H2O2 arise from its metal-catalyzed conversion into OH by the Fenton and Haber–Weiss reactions [28].
Mitochondrial DNA and the ETC complexes are considered to be the primary targets of free radical attack and this may increase O2•− production due to the altered function of ETC proteins or to the decreased expression of critical ETC proteins encoded by the mitochondrial genome [29,30].
Mitochondria are also central in regulating the Ca2+ homeostasis that plays a crucial role in cell physiology and pathology. Mitochondrial Ca2+ uptake, driven by ΔΨm, regulates the levels and spatio-temporal patterns of intracellular Ca2+ signals [31]. Both Ca2+ and ROS act as second messengers in cell signaling and interact with each other bidirectionally. In fact, ROS can regulate intracellular Ca2+, and increased Ca2+ levels can activate ROS generation [32]. Ca2+ ions freely permeate through the OMM and enter the mitochondrial matrix via the Ca2+ uniporter located in the IMM [33].
Moreover, mitochondrial Ca2+ and ROS [34] are the two main activators of a large conductance channel, the mitochondrial permeability transition pore (mPTP) whose opening increases the permeability of IMM to solutes up to1500 Da leading to depolarization, Ca2+ and ROS release [5]. Transient short-term openings of mPTP are thought to fulfill physiological functions through release of Ca2+ and ROS, whereas prolonged openings lead to rapid collapse of the ΔΨm, the consequent ATP loss, as well as osmotic shock causing the rupture of the OMM. These events finally result in necrosis [35,36,37] but can also cause the release of the mitochondrial pro-apoptotic factors, cytochrome C, apoptosis-inducing factor, activator of caspases, and endonuclease G, leading to apoptosis [38,39,40,41].

3. Roles of Sperm Mitochondria

Mammalian sperm generally have approximately 50 to 80 mitochondria, tightly wrapped to form a mitochondrial sheath in the midpiece of the flagellum [42,43]. Mitochondria are essential in several sperm functions and through ATP production, they regulate spermatogenesis, capacitation, induction of acrosome reaction, oocyte fusion, and fertilization [44,45,46]. Several reports indicate that motility and fertility of human sperm is closely correlated with mitochondrial function and these organelles have been indicated as biomarkers of sperm quality in several species [47,48,49]. Mitochondrial membrane potential and respiratory efficiency have been positively correlated with human sperm motility [50,51] and several studies proposed that assessment of ΔΨm predicts the sperm fertilization competence both in natural conception and in vitro fertilization (IVF) [52,53,54,55]. Recently, high ΔΨm has been suggested to be necessary for acrosin activity, induction of acrosome reaction and maintenance of chromatin integrity of human sperm [56].
Mutations of sperm mtDNA have been associated with decreased sperm quality and may impact the efficiency of OXPHOS as several ETC proteins are encoded by mtDNA. In particular, a lack of efficient mtDNA repair mechanisms in sperm [57] has been linked to the occurrence of a more rapid accumulation of mutations than in somatic cells [45]. Sperm mtDNA mutations found in asthenozoospermic and oligoasthenozoospermic men have been reported to compromise semen quality [58,59]. Moreover, an inverse relationship has been reported between sperm mtDNA copy number, and semen quality and fertility [60,61,62], although the outcome of intracytoplasmic sperm injection (ICSI) was not affected [63].
Mitochondria also represent the major source of ROS and reactive nitrogen species (RNS) in sperm and have a central role in redox signaling that drives fundamental events in the sperm life such as the activation of motility, hyperactivation, capacitation, acrosome reaction, and fertilization [64] (Figure 1). However, oxidative and nitrosative stress caused by excessive ROS and RNS production respectively, have been identified as the major cause of male infertility [65]. In fact, spermatozoa are extremely prone to ROS-induced damage as they contain modest antioxidant defenses and a high content of oxidizable substrates [66,67,68]. In particular, the sperm plasma membrane is rich in polyunsaturated fatty acids that regulate membrane fluidity, but also represent preferential substrates for ROS attack. This, in turn, triggers a lipid peroxidation cascade and the consequent generation of highly reactive lipid aldehydes that covalently bind to ETC proteins reinforcing the production of mitochondrial ROS and compromising both the competence and the DNA integrity of the spermatozoa [69,70,71].

4. Effects of Sperm Cryopreservation on Mitochondria and Oxidative Stress

Sperm cryopreservation has become a routine procedure in human ART and is a common method for preserving and transporting genetic material in most domestic species. Nonetheless, an impressive plethora of evidence on human and domestic animals indicates that sperm cryopreservation decreases the number of viable sperm and can affect the functions of surviving cells by impairing their motility, mitochondrial activity, chromatin integrity, and reproductive potential [72,73,74,75,76]. Slow-freezing procedures, the first historically developed techniques to successfully cryopreserve spermatozoa, remain the most commonly used techniques [77], probably because the high sperm number generally present in ejaculates make survival rates acceptable. On the other hand, spermatozoa in poor-quality ejaculates are more prone to cryoinjuries and the possibility to recover viable sperm post-thawing has been reported to be difficult in severely oligozoospermic patients [78]. Adverse effects of cryopreservation on sperm motility, DNA integrity, and sperm competence were reported especially in subfertile and infertile men [79,80,81]. OS is regarded as one of the main factors underlying both male infertility and the reduced survival and competence of sperm observed after cryopreservation. This is particularly concerning as, at least in non-human mammals, sperm OS has been correlated with a significant reduction in fertilization rates and in vitro embryo development [82,83,84,85]. Hence, it is important to look for causes and remedies of cryopreservation-associated sperm damage. This may lead to refine cryopreservation procedures through pre- or post-treatment with antioxidants to improve the survival and competence of sperm of infertile patients or those of animal species that scarcely tolerate the stress imposed by cryopreservation. DNA damage and loss of mitochondrial function have been commonly associated with cryopreservation of mammalian sperm and together with ROS levels represent the more frequently assessed endpoints in studies aimed to improve the outcome of the procedure [86]. Changes of mitochondrial membrane fluidity occurring during cryopreservation have been suggested to raise ΔΨm and to induce the release of ROS. Released ROS, in turn, cause DNA damage leading to single/double-strand DNA breaks [87].
Detailed studies on the relevance of mitochondrial damage on the decreased performance of frozen–thawed mammalian sperm are available in domestic animals. In ovine spermatozoa, mitochondrial cryoinjuries reduce the ability of frozen–thawed sperm to migrate through the cervix and survive in the female reproductive tract [88]. Opening of the mPTP seems to be involved in sperm cryodamage in different species. The first indirect evidence of such an involvement has been reported in the stallion in which supplementation of sperm freezing media with bongkrekic acid, an inhibitor of mPTP opening, reduced active caspases and increased ΔΨm in thawed sperm [89]. Recent studies on cryopreserved bull sperm confirmed that mitochondrial dysfunction is due to the opening of the mitochondrial permeability transition pore in response to intracellular Ca2+ increases and this was associated with loss of ΔΨm, decreased ATP content, increased ROS levels, and deterioration of plasma membrane integrity [90]. The involvement of mPTP opening in sperm cryopreservation has been confirmed in ram and the ability of the mitochondrial antioxidant melatonin to prevent this effect was carefully assessed [91,92]. Melatonin is an antioxidant localized and mainly synthesized in mitochondria that is actively accumulated via mitochondrial melatonin transporter. Melatonin maintains ΔΨm and preserves mitochondrial functions through scavenging of both ROS and RNS, inhibition of mPTP opening, and it also acts as a signaling molecule that up-regulate the expression of antioxidant enzymes and stress responsive genes [93]. On this basis, melatonin has been used to prevent cryoinjuries related to mitochondria and OS during cryopreservation of human and domestic animal sperm. In 2011, Succu et al., [94] demonstrated that the addition of melatonin to ram semen freezing extender led to higher viability, motility, intracellular ATP levels, and DNA integrity compared to semen frozen in non-supplemented extenders. In addition, melatonin-treated sperm had better performance in IVF compared to control frozen–thawed sperm, showing higher fertilization rates and a reduction of time to the first embryonic division [94] likely due to decreased sperm DNA damage and a faster repair in the zygote. More recent studies show that melatonin supplementation of ram sperm freezing media inhibits mPTP opening, leading to improvements in key OXPHOS enzymes, oxygen consumption, ATP synthesis, and sperm viability, motility and kinetics [91,92]. Melatonin supplementation during the 4 °C equilibration period was most effective for inhibiting mPTP opening, decreasing the enzymatic activity of Cyclophilin D (a key mediator of mPTP opening), and increasing plasma membrane integrity, ΔΨm, and mitochondrial Cyt C concentration. Moreover, melatonin-treated frozen–thawed sperm produced higher hatching blastocysts and pregnancy rates after IVF and artificial insemination respectively [92]. Overall, considerable direct evidence in domestic animals suggest mPTP opening as a common denominator of sperm cryodamage.
In human sperm, supplementation of freezing media with melatonin increased sperm viability and membrane integrity, decreasing ROS and lipid peroxidation. Moreover, melatonin increased mRNA levels of the transcription factor NF-E2-related factor-2 and its downstream genes which play a critical role in the defense against OS, and up-regulated the expression of the antiapoptotic genes Bcl-2 and heat shock protein 90 (HSP90), which confers resistance to stressors in frozen–thawed sperm [95]. Najafi et al. showed that supplementation of human sperm freezing media with melatonin increases AKT phosphorylation, and decreases ROS, caspase-3 activity, and both dead and apoptotic-like sperm via the PI3K/AKT signaling pathway [96]. A more recent study indicated that supplementation of human sperm freezing solution with melatonin, followed by thawing in the presence of both melatonin and caffeine, prevented the loss of progressive motility and mitochondrial activity in sperm of normozoospermic men. However, this treatment failed to prevent the increase of DNA fragmentation and ROS production compared to fresh samples [97].
Based on literature data on cryopreservation-associated mitochondrial dysfunction in sperm of different species, it can be speculated that cryoprotectant-induced Ca2+ overload might induce prolonged openings of mPTP leading to ROS and Ca2+ release, loss of ΔΨm, decreased ATP content, and release of Cyt C (Figure 2).
Mitochondria-targeted antioxidants have been generally designed through a combination of antioxidants with the lipophilic cation triphenylphosphonium (TPP) which drive their massive accumulation in a ΔΨm dependent manner to extinguish oxidative stress in pathological mitochondria [98]. Supplementation of cell permeable ROS scavenger MitoTEMPO, a combination of the antioxidant piperidine nitroxide TEMPO and TPP [99] in commercial sperm freezing media has improved post-thaw sperm motility, viability, ΔΨm, antioxidant enzymes activities, and decreased ROS levels and malondialdehyde (MDA) content in human normozoospermic and asthenozoospermic ejaculates [100,101].
MitoQ or mitoquinone is one of the most well characterized mitochondrial-targeted antioxidants and consists of oxidized CoQ10 moiety conjugated to TPP to facilitate accumulation within the mitochondria [102]. MitoQ significantly decreased ROS production, as well as lipid peroxidation, and increased post-thaw viability in yellow catfish sperm [103]. Addition of MitoQ to the freezing extender has been reported to improve the quality of human sperm by decreasing ROS and MDA levels and preventing ΔΨm loss in thawed sperm [104].
Elamipretide, also known as SS-31, a water-soluble and permeant tetrapeptide that selectively binds cardiolipin, is the first cardiolipin-protective compound used as a therapeutic agent in a variety of mitochondrial diseases [105]. Cardiolipin, a phospholipid exclusively localized on IMM, plays an important role in cristae formation and the assembly of ETC complexes into supercomplexes for optimal OXPHOS and is considered a platform for initiation of apoptosis [105]. Oxidized cardiolipin transforms cytochrome c into a peroxidase leading to further cardiolipin oxidation, release of cytochrome c and apoptosis [106]. Cardiolipin is present in the mitochondria in human and rat testis and is the substrate for the synthesis of a fully saturated form of cardiolipin found exclusively in extramitochondrial locations such as the acrosome membranes [107,108,109]. Interestingly, a recent study demonstrated that Elamipretide was able to protect cryopreserved human sperm improving their motility, viability, acrosomal function, membrane and chromatin integrity, ΔΨm, antioxidants enzyme activities, and preventing the increase of ROS and MDA associated with cryopreservation [110]. The fact that acrosomal function of frozen–thawed sperm was improved could indicate that Elamipretide protects both mitochondrial cardiolipin and the newly discovered acrosomal saturated cardiolipin. Incubation with micelles containing a mitochondrial-like mixture of glycerolphospholipids, including the key precursor of cardiolipin, phosphatidylglycerol, improves the viability, motility and the resistance to oxidation of human sperm [111].
Among the non-enzymatic mitochondrial ROS scavengers, a major role is played by the lipid-soluble antioxidant vitamin E, which reacts with the peroxyl radicals faster than the molecules of polyunsaturated fatty acids, and in doing so, protects membranes from excessive oxidative damage [112]. Several studies evaluating the ability of alfa-tocopherol, an active form of vitamin E, to protect mammalian sperm from OS associated with cryopreservation showed decrease of ROS and lipid peroxidation, and improvements of post-thaw motility, ΔΨm and DNA integrity [113,114,115,116,117,118,119]. Recently, both alpha and gamma tocopherol have been identified in human seminal plasma and the supplementation of freezing media with gamma tocopherol induced a higher post-thaw human sperm viability and motility than alpha-tocopherol [120]. Interestingly, the use of nano-emulsions containing vitamin E to protect it from oxidation has been demonstrated to protect acrosome integrity and mitochondrial activity of frozen–thawed red deer sperm, preventing sperm lipoperoxidation and reducing ROS production [121].
L-carnitine plays a crucial role in sperm health by facilitating the transport of activated fatty acids across the IMM, so that they can be broken down through beta-oxidation to produce ATP [122]. Zhang et al., showed that supplementation of cryopreservation media with l-carnitine reduced spermatozoa cryodamage in both asthenozoospermic and normozoospermic human semen samples [123].

5. Roles of Oocyte Mitochondria

Mitochondria are inherited exclusively from the cytoplasm of the fertilized oocyte as sperm mitochondria are actively excluded from the zygote to limit heteroplasmy and its detrimental consequences on development and health of the offspring [124]. Due to the absence of protective histones, low DNA repair ability, and its proximity to the ROS producing ETC, mitochondrial DNA (mtDNA) is 10- to 50-fold more prone to mutations than nuclear DNA [125].
During embryo development, a bottleneck positioned between the primordial germ cells and the primary oocyte dramatically reduces mtDNA copy numbers, preventing the accumulation of mutant mtDNA in the maternal germ line and heteroplasmy in the offspring [126]. During human folliculogenesis, mtDNA copy number increases from about 500 copies in primary oocytes to 150,000–700,000 copies in mature oocytes [127]. The mature human oocyte is the richest cell in terms of mtDNA content, which is required to acquire competence for fertilization and for the embryo to reach the blastocyst stage [128]. Oocyte’s mitochondrion is considered immature and it has a round or oval shape, few cristae, a dense matrix and generally one or two mtDNA genomes [129]. As mtDNA replication ceases until later stages of pre- or post-implantation development, each embryo cleavage halves the number of mitochondria per cell until mitochondrial replication is resumed [130,131]. Therefore, until this stage the embryo relies exclusively on the mitochondrial pool inherited from the oocyte. At this time, a transition occurs, and the mitochondria acquire an elongated shape, a lighter matrix and numerous transverse cristae and increase their oxygen consumption and OXPHOS [132].
Despite their immature appearance, oocyte mitochondria are active in OXPHOS and their ATP production is required for several essential events such as oocyte maturation, spindle assembly, polar body extrusion, chromosome segregation, fertilization, and embryo development [14,130].
Mitochondrial membrane potential, OXPHOS, and oocyte ATP levels increase during oocyte maturation [133,134,135,136]. Oocytes ATP levels have been positively correlated with fertilization rates and embryo development and ATP content ≥ 2 pmol/oocyte is needed to support normal embryo development [134,137,138].
Oocyte mitochondria are involved in Ca2+ homeostasis and Ca2+ oscillations at fertilization and these, in turn, regulate correct embryo development [14,139]. In fact, sperm-triggered cytosolic Ca2+ transients directly stimulate mitochondrial activity, and the latter is absolutely required to maintain basal cytosolic Ca2+ levels in the unfertilized oocyte and to recover the basal level after each Ca2+ transient at fertilization [139]. Subplasmalemmal highly polarized mitochondria of mammalian oocytes have been suggested as a prerequisite for fertilization competence [140]. Mature mouse and human oocytes with a reduced complement of subplasmalemmal mitochondria cannot be penetrated by sperm [135,140]. In addition, evidence in different species, from marine invertebrates to mice and bovines, indicates that sperm penetration drives a burst of H2O2 production and oxygen consumption suggesting that mitochondrial activity is stimulated by Ca2+ increases around the time of sperm penetration [11,12,14,141]. Elegant experiments on transgenic Xenopus laevis oocytes expressing the H2O2 indicator HyPer demonstrated that intracellular Ca2+ waves are necessary and sufficient to induce a rapid increase of mitochondrial H2O2 production at fertilization which oscillate with each cell division during embryo development. Moreover, ROS oscillations have been suggested to modulate the cell cycle through phosphatase Cdc25C and attenuation of mitochondrial ROS production blocked the cell cycle [17] (Figure 3).
The pivotal role of mitochondria, and their dysfunctions, as determinants of oocyte quality and embryo developmental potential has been clearly recognized in patients of advanced reproductive age, or with obesity, diabetes, and other metabolic disorders [142,143]. Reproductive aging has been associated with reduced ΔΨm and ATP production, altered gene expression, increased ROS generation and accumulation of mtDNA mutations both in human and in animal models [144,145,146,147] and these can in turn induce spindle damage, chromosome misalignment and aneuploidy [148,149]. A decreased expression of the mitochondrial antioxidant genes, peroxiredoxin 3 and thioredoxin 2, has been reported in aged mice oocytes [150]. Aging also affects mtDNA copy number and ATP levels in different species and a decreased copy number has been reported in older than in younger oocytes or embryos [151,152,153]. The determination of mtDNA copy number in oocyte granulosa cells or in blastocyst’s trophectoderm biopsies has been recently suggested as a method to predict the embryo quality [154]. Graded mitochondrial injury in mouse oocytes suggested that the extent of mitochondrial injury determines whether the oocyte dies or the resulting embryo will proceed through the early embryo development before death occurs [155].
Several approaches have been developed for replacing dysfunctional mitochondria of poor-quality oocytes with healthy mitochondria to restore oocyte quality [156]. These approaches have also been used as a therapy to eliminate mitochondrial mutations and prevent the transmission of mtDNA disorders [157,158,159]. Although 25 babies were born through injection of donor oocyte cytoplasm so far, this procedure has been discontinued for concerns of heteroplasmy or transmission of mitochondrial diseases from the donor [160,161,162]. New procedures relying on the transfer of autologous sources of mitochondria from the patient’s granulosa or ovarian stem/precursor cells to ensure the provision of high-quality homologous mitochondria with intact and homoplasmic mtDNA could represent promising tools to restore oocyte quality [163].
Taken together, this evidence emphasizes the essential role of mitochondria as determinants of oocyte quality and any insult disturbing mitochondrial replication and/or functioning might potentially impair oocyte competence.

6. Effects of Oocyte Cryopreservation on Mitochondria, Oxidative Stress, Fertilization, and Embryo Development

During the last two decades, great efforts were devoted to the development of successful protocols for oocyte cryopreservation to avoid the ethical and legal problems connected to embryo cryopreservation, to preserve female fertility, and to manage oocyte donation [164,165,166]. Although the first births from human cryopreserved oocytes were reported more than 30 years ago [167,168], the initial slow-freezing procedures adopted, and their variations had a very limited success rate and oocyte cryopreservation did not spread worldwide until Kuwayama and collaborators [169] proposed vitrification as an elective strategy to maintain the developmental competence of cryopreserved oocytes. Oocyte vitrification has become a routine technology in human ART and fertility preservation programs and is no longer considered experimental [170]. Initial attempts to cryopreserve oocytes were profoundly limited by their imperfect methodologies, with the consequence being poor clinical outcomes. In fact, several studies demonstrated that during slow-freezing, cellular and molecular alterations associated with osmotic forces produced during oocyte dehydration–rehydration cycles or by cryoprotectants may affect the molecular architecture of the meiotic spindle and chromosomes, as well as the distribution and activity of other cytoplasmic components [171]. On the other hand, oocyte vitrification, in which intracellular and extracellular fluid is transformed from a liquid into a glassy amorphous solid state, retains the distribution of molecules and ions and reduces damages to oocytes, exhibiting a better clinical outcome than that of slow-freezing [172,173,174,175].
Studies on reproductive cells from different species have indicated that cryopreservation induces alterations and/or damages to the mitochondria [176,177,178]. A more detailed comprehension of the effects of cryopreservation on mitochondrial function and OS has been achieved for sperm of different species, whereas only a partial and fragmentary knowledge is available for oocytes.
Studies have shown that cryopreservation by slow-freezing process could alter oocyte ΔΨm but not inducing early apoptotic response [179,180]. Similarly, vitrification of mouse oocytes can alter mitochondrial distribution and reduce the ΔΨm [181] which was also found to be age related [182]. On the other hand, it was found that oxidation of the intracellular redox potential by vitrification was independent of age [183]. Vitrification significantly reduces the ATP content in bovine, human, rabbit, murine, and porcine oocytes [184,185]. It has been suggested that the rapid entry of cryoprotectants into the oocytes can cause irreversible damage to cell organelles, including mitochondria [186]. Since vitrification uses higher concentrations of cryoprotectants, and a mature oocyte’s cytoplasm is normally more hydrated than in embryos, the extent of impact on cell architecture could be higher. This has been supported by the fact that vitrification can severely damage mitochondria, alter the expression of mitochondria functional genes in bovine mature oocytes when cryopreserved at immature stage and these changes are found to be related to the concentrations of cryoprotectants used [187]. Mouse prepubertal oocytes cryopreserved after in vitro maturation (IVM) have shown lower ΔΨm than prepubertal oocytes cryopreserved at germinal vesicle stage [188]. In contrast, no significant alteration in mitochondrial distribution was observed between human oocytes cryopreserved before and after IVM [189]. Interestingly, vitrification-warming of human mature oocytes resulted in either a transient reduction of the ΔΨm [190] or failed to demonstrate any changes in ΔΨm and intracellular ROS levels [183]. In mouse oocytes, all the permeant cryoprotectants used in slow-freezing and vitrification cause intracellular Ca2+ rises comparable to the initial increase triggered at fertilization. More specifically, both ethylene glycol and propanediol vehiculate Ca2+ from the external medium, propanediol exerting a more powerful and long-lasting Ca2+ rise, whereas dimethyl sulfoxide (DMSO) releases Ca2+ from internal stores [191,192]. By fact, use of Ca2+-free media, extracellular or intracellular Ca2+ chelation has been reported to improve oocyte vitrification in mouse, ovine, bovine [94,185,191,192,193,194].
Bovine oocyte vitrification, especially with DMSO, has been showed to trigger the release of Ca2+ from the endoplasmic reticulum leading to abnormally increased cytosolic and mitochondrial Ca2+ levels. This was associated with cortical granules exocytosis, decreased ΔΨm, ATP content, increased TUNEL positivity, and reduced cleavage and blastocysts rates. Treatment with the intracellular Ca2+ chelator BAPTA and the mitochondrial Ca2+ uniporter inhibitor ruthenium red during vitrification decreased cytosolic and mitochondrial Ca2+ respectively. Moreover, it also improved cleavage and blastocysts rates, as well as the expression of genes related to blastocysts apoptosis and implantation, to levels similar to fresh oocytes. The decreased ΔΨm and ATP content of vitrified bovine oocytes was suggested to derive from mitochondrial membrane permeability transition in response to mitochondrial Ca2+ overload [185].
Mitochondrial Ca2+ overload and OS can drive cell damage and death through opening of the mPTP that affects the ΔΨm, Ca2+ homeostasis, ATP and ROS production [195,196,197,198]. Evidence indicates that mPTP opening is a cause of damage during cryopreservation of sperm (see above), whereas such an involvement has poorly been investigated in oocytes. However, pretreatment of mouse oocytes with the specific inhibitor of mPTP, cyclosporine A, before H2O2 exposure, has been reported to prevent ΔΨm loss and ATP reduction, thus increasing the developmental potential of oocytes [155]. In addition, pretreatment of bovine oocytes with cyclosporine A before vitrification prevented the increase of ROS in oocytes, and increased the blastocyst rate and ATP content of blastocysts derived from parthenogenetically activated vitrified oocytes [184].
Oocyte mitochondria play a key role in the generation of intracellular Ca2+ transients at fertilization and their alterations may exert long-term detrimental effects on pre- and post-implantation development [199,200,201]. Gualtieri et al. suggested that loss of ΔΨm and mitochondria ultrastructural degeneration found in human oocytes cryopreserved through the 0.3-M sucrose slow-freezing method could compromise oocyte Ca2+ signaling and developmental competence [180], contributing to the reduced clinical outcome of this procedure [202,203,204]. Analysis of intracellular Ca2+ response to ionomycin in cryopreserved human oocytes showed a marked delay in recovery of Ca2+ basal levels in slow-frozen and not in vitrified oocytes. These findings agree with the lower mitochondrial damage found in vitrified versus slow-frozen oocytes [205]. Although a direct relationship with mitochondrial damage is lacking, vitrification of mouse oocytes has also been found to affect Ca2+ signaling [206,207].
Several studies demonstrate clear links among oocyte cryopreservation, mitochondrial damage, OS, and embryo development in animal models. Decrease in ΔΨm and increase in ROS levels were reported in vitrified mouse [180] and porcine oocytes where, in addition, mitochondria ultrastructural damage, decrease of ATP content and dysregulation of mitochondria and apoptosis-related genes were also reported [208,209]. A hypothetical mechanism of mitochondrial dysfunction associated with oocyte cryopreservation is proposed in Figure 4.
Oocyte cryopreservation-induced sub-lethal injuries such as OS induced DNA damage, altered metabolism, transcription and translation abnormalities may not be detectable morphologically but a significant number of such oocytes eventually may fail to get fertilized [210]. From the clinical perspective, it is important to know that only ~2% of human oocytes cryopreserved through slow-freezing can develop to term while majority of them survive cryopreservation [211]. Mitochondrial dysfunction in oocytes has been correlated with embryo arrest in vitro [155]. Slow-freezing and vitrification similarly affect the genes involved in oxidation-reduction pathway in cleavage stage preimplantation embryos derived from cryopreserved mouse oocytes [212,213].
Abnormal expression of apoptotic and mitochondria-related genes in bovine embryos derived from the vitrified oocytes were associated with vitrification temperature and the concentration of cryoprotectants used [187]. Furthermore, the disruptions in the embryonic genome activation due to oocyte cryoinjury can impair several essential processes in embryos including mitochondrial function [212]. Though mtDNA content in human blastocysts was not affected by the oocyte vitrification [214], it should be noted that the copy number of mtDNA alone cannot reflect the mitochondrial turnover hence, further studies are required to better understand the mitochondrial integrity between fresh and vitrified sibling oocytes in human.
Mammalian oocytes have large cytoplasm with abundant mitochondria in the ooplasm which can experience structural and functional damage during the cryopreservation process. Therefore, reduction in viability and post-thaw developmental competence can be correlated with the extent of mitochondrial damage in oocytes. A minimum of 2 to 4 h may be required for recovery of mitochondrial function following vitrification in porcine oocytes [215]. Antioxidants such as melatonin, N-acetyl cysteine and, combination of ascorbic acid and rosmarinic acid have shown to improve the cryosurvival of the mouse oocytes and enhance their developmental potential [216,217,218]. Alpha-tocopherol treatment during recovery culture improved development of embryos generated from vitrified-warmed bovine oocytes [219]. Moawad et al., demonstrated that l-carnitine supplementation during vitrification of Germinal vesicle (GV) stage oocytes reduced the mitochondrial aggregation and improve the distribution pattern along with improved spindle organization and nuclear maturation of mouse oocytes subjected to IVM [220]. Similarly, supplementation of glutathione donor, glutathione ethyl ester (GEE), in cryopreservation medium has shown to improve the cryotolerance of mouse oocytes by preventing the loss of mitochondrial function [221] and reducing the oxidative stress in bovine oocytes [222]. Furthermore, Li et al. have shown that pre-incubation of mouse oocytes with GEE enhances the developmental competence of vitrified oocytes by preventing the mitochondrial damage and altering the expression of pro- and anti-apoptotic genes [223].

7. Effects of Gonadal Tissue Cryopreservation on Mitochondria and Oxidative Stress

Gonadal tissue cryopreservation has gained attention in recent years due to its application in fertility preservation field [224]. Various protocols have been followed to store ovarian and testicular tissues from prepubertal and young adults. In either case, due to the complexity of the tissue, designing an optimal cryopreservation protocol is technically challenging. Even though preserving the integrity of the germ cells is the key interest in such situation, retaining the architecture of extracellular matrix, communication between different cell types and preserving the organelle function are very critical. Mitochondria being the major source of OS, is expected to undergo functional changes after cryopreservation process.
Mitochondria are considered to be the most sensitive organelles in oocytes [225]. Altered distribution patterns, and ultrastructural damage of mitochondria was observed in oocytes of frozen–thawed human ovarian tissue and of vitrified mouse ovarian tissue [226,227]. Mitochondrial damage in human ovarian tissues, specifically in oocytes has been reported during freeze-thaw process by earlier studies which may have a significant effect on follicle growth [228,229]. However, conventional liquid nitrogen and ultra-rapid slush nitrogen vitrification did not affect mitochondrial ultrastructure [230] even though the expression analysis of genes involved in OS, hypoxia, osmotic stress, and cell death, demonstrated a markedly higher dysregulation in conventional versus ultra-rapid vitrification [231]. Ultrastructural assessment of mitochondrial organization may be considered to be a parameter to evaluate the efficiency of cryopreservation protocol; however, the mitochondrial dysfunction need not be always associated with morphological changes. Cryopreservation of mouse ovarian tissue by the slow-freezing technique resulted in a significantly higher level of ROS and DNA fragmentation in oocytes in comparison to vitrification [232]. Increased level of free Ca2+ and reduction in ATP level was observed in oocytes of vitrified mouse ovaries [233]. Moreover, vitrification of rat ovaries has been reported to increase ROS, malondialdehyde and nitric oxide levels, and the addition of the mitochondrial antioxidant melatonin to the vitrification solutions protected follicular integrity preventing such effects and increasing the activities of glutathione peroxidases, glutathione, catalase, and superoxide dismutase [234].
Overall, mitochondrial changes in oocytes and stromal cells are a common observation in ovarian tissue cryopreservation suggesting there is still scope of improvement in designing the protocol.
The impact of cryopreservation on mitochondria and OS in testicular tissue has been poorly addressed. However, cryopreservation has been reported to induce OS in mouse, bovine, and human testicular tissue. In the mouse, an increased ROS production was reported in frozen–thawed versus fresh tissue and vitamin E and not GSH supplementation of culture media after thawing decreased ROS levels and enhanced sperm differentiation in vitro [235]. In bovine, testicular tissue cryopreservation decreased total antioxidant, catalase and superoxide dismutase activities, and led to an increase of malondialdehyde content. Addition of 15% trehalose reduced the OS and improved the cryoprotective effects [236].
Although Moubasher et al. did not find increased malondialdehyde production in frozen–thawed testicular tissues of patients with obstructive or non-obstructive azoospermia, catalase activity was higher in cryopreserved tissue of obstructive azoospermic patients suggesting that testicular tissue of such patients withstand OS induced by cryopreservation better than non-obstructive azoospermic patients [237].
The mitochondrial integrity in the testicular cells may depend upon the type of penetrating cryoprotectant used in freezing medium. Keros et al. compared the efficacy of penetrating cryoprotectants—glycerol, dimethyl sulfoxide (DMSO)—and propanediol for human testicular tissue. In spermatogonial cells, glycerol resulted in swollen mitochondria characterized by dilated cristae; propanediol resulted in heterogeneously shaped matrix in mitochondria; while DMSO preserved the morphology, which was similar to control. Based on these findings on mitochondrial integrity and cell survival, Keros et al. recommend DMSO as an ideal penetrating cryoprotectant for testicular tissue cryopreservation [238].
Studies on improving the outcome of gonadal tissue cryopreservation are limited unlike on gametes. Trehalose, a widely used non-penetrating cryoprotectant, has shown to effectively mitigate the OS in bovine calf testicular tissue during cryopreservation [236]. Ha et al., reported that addition of hypotaurine to DMSO-based freezing medium significantly improves the post-thaw mitochondrial activity in mouse spermatogonial stem cells (SSCs) [239]. Supplementing vitamin E to the mice prepubertal testicular tissue cryopreservation medium reduced the OS and improved the in vitro sperm production [235]. Similarly, in ovarian tissue, Fabbri et al., demonstrated better survival of oocytes and mitochondrial function in ovaries frozen with 30% human serum compared to 20% human serum as well as 20% fetal calf serum [240]. In a study conducted on human ovarian tissue, Talevi et al., observed that replacing sodium with choline in slow cryopreservation medium not only helps in eliminating the risk of sodium toxicity on oocytes, but it also significantly decreases the mitochondrial ultrastructural damage. In addition, stromal cells in ovarian tissue were better preserved [228]. However, to ascertain the beneficial role of using antioxidants or free radical scavengers in freezing medium of gonadal tissues needs to be validated by further studies to assess their ability to give rise to an oocyte or spermatozoa under in vitro conditions and their ability to regenerate after transplantation.

8. Concluding Remarks

Development and refinement of cryopreservation procedures have been fundamental in human and animal assisted reproduction and fertility preservation. However, depending on the species and the quality of gametes, cryopreservation can decrease sperm and oocytes’ performance and, ultimately, the dynamics of fertilization and embryo development.
Although evidence demonstrates that mitochondrial dysfunction and OS are two common consequences arising from cryopreservation of somatic and reproductive cells, systematic studies addressing the mechanisms inducing such damage in gametes are limited. Herein, based on literature reviewed, we propose hypothetical mechanisms of cryopreservation-associated mitochondrial dysfunction in gametes. Ca2+ overload induced by permeating cryoprotectants and increased ROS could cause mPTP prolonged openings triggering further ROS generation, rupture of mitochondrial membranes, Cyt C release and eventually leading to cell death. Mitochondrial sub-lethal damage in thawed or warmed cryopreserved reproductive cells can reduce their performance according to the roles played by mitochondria in sperm, oocytes, and gonadal tissues.
Overwhelming evidence indicates that treatment with a wide range of antioxidants and other means, before and during cryopreservation or after thawing/warming, can prevent or reduce mitochondrial dysfunction and OS thereby improving the reproductive potential. However, systematic comparative studies on the differential protective effects of antioxidants on cryopreserved reproductive cells are seldom present in the literature. Several studies show that mitochondrial antioxidants can ameliorate the cryopreservation outcome, whereas fewer studies have been made with mitochondria-targeted antioxidants. Despite encouraging findings on the efficacy of several antioxidants and other treatments in the prevention of mitochondrial cryoinjuries and OS, further studies are warranted before their introduction in the clinical setting. Finally, as mitochondrial ROS drive specific signaling events in reproductive cells, the careless use of antioxidant type, concentration and exposure time may reduce or ablate mitochondrial or cytoplasmic ROS below physiological thresholds leading to a reductive stress and the consequent deregulation of ROS-induced signaling.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Spallanzani, L. Opuscoli di Fisica Animale e Vegetabile; Presso la Società Tipografica: Modena, Italy, 1776; Volume 2, p. 2. [Google Scholar]
  2. Polge, C.; Smith, A.; Parkes, A. Revival of spermatozoa after vitrification and dehydration at low temperatures. Nature 1949, 164, 666. [Google Scholar] [CrossRef]
  3. Plotnikov, E.Y.; Zorov, D.B. Pros and cons of use of mitochondria-targeted antioxidants. Antioxidants 2019, 8, 316. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Collin, F. Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int. J. Mol. Sci. 2019, 20, 2407. [Google Scholar] [CrossRef] [Green Version]
  5. Zinovkin, R.A.; Zamyatnin, A.A. Mitochondria-Targeted Drugs. Curr. Mol. Pharmacol. 2019, 12, 202–214. [Google Scholar] [CrossRef] [PubMed]
  6. de Lamirande, E.; Gagnon, C. Impact of reactive oxygen species on spermatozoa: A balancing act between beneficial and detrimental effects. Hum. Reprod. 1995, 10, 15–21. [Google Scholar] [CrossRef]
  7. Talevi, R.; Zagami, M.; Castaldo, M.; Gualtieri, R. Redox regulation of sperm surface thiols modulates adhesion to the fallopian tube epithelium. Biol. Reprod. 2007, 76, 728–735. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Starkov, A.A. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann. N. Y. Acad. Sci. USA 2008, 1147, 37–52. [Google Scholar] [CrossRef] [Green Version]
  9. Gualtieri, R.; Mollo, V.; Duma, G.; Talevi, R. Redox control of surface protein sulphhydryls in bovine spermatozoa reversibly modulates sperm adhesion to the oviductal epithelium and capacitation. Reproduction 2009, 138, 33–43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Aitken, R.J. Reactive oxygen species as mediators of sperm capacitation and pathological damage. Mol. Reprod. Dev. 2017, 84, 1039–1052. [Google Scholar] [CrossRef] [PubMed]
  11. Nasr-Esfahani, M.H.; Aitken, J.R.; Johnson, M.H. The origin of reactive oxygen species in mouse embryos cultured in vitro. Development 1991, 113, 551–560. [Google Scholar] [PubMed]
  12. Schomer, B.; Epel, D. Redox changes during fertilization and maturation of marine invertebrate eggs. Dev. Biol. 1998, 203, 1–11. [Google Scholar] [CrossRef] [PubMed]
  13. Dumollard, R.; Ward, Z.; Carroll, J.; Duchen, M.R. Regulation of redox metabolism in the mouse oocyte and embryo. Development 2007, 134, 455–465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Dumollard, R.; Duchen, M.; Carroll, J. The role of mitochondrial function in the oocyte and embryo. Curr. Top. Dev. Biol. 2007, 77, 21–49. [Google Scholar] [PubMed]
  15. Morado, S.A.; Cetica, P.D.; Beconi, M.T.; Dalvit, G.C. Reactive oxygen species in bovine oocyte maturation in vitro. Reprod. Fertil. Dev. 2009, 21, 608–614. [Google Scholar] [CrossRef]
  16. Lopes, A.S.; Lane, M.; Thompson, J.G. Oxygen consumption and ROS production are increased at the time of fertilization and cell cleavage in bovine zygotes. Hum. Reprod. 2010, 25, 2762–2773. [Google Scholar] [CrossRef] [Green Version]
  17. Han, Y.; Ishibashi, S.; Iglesias-Gonzalez, J.; Chen, Y.; Love, N.R.; Amaya, E. Ca2+-induced mitochondrial ROS regulate the early embryonic cell cycle. Cell. Rep. 2018, 22, 218–231. [Google Scholar] [CrossRef] [Green Version]
  18. Sies, H. Oxidative stress: Introductory remarks. In Oxidative Stress, 1st ed.; Sies, H., Ed.; Academic Press: London, UK, 1985; pp. 1–8. [Google Scholar]
  19. Sies, H.; Jones, D.P. Oxidative stress. In Encyclopedia of Stress, 2nd ed.; Fink, G., Ed.; Elsevier: Amsterdam, The Netherlands, 2007; pp. 45–48. [Google Scholar]
  20. Sies, H.; Berndt, C.; Jones, D.P. Oxidative stress. Annu. Rev. Biochem. 2017, 86, 715–748. [Google Scholar] [CrossRef] [PubMed]
  21. Shoshan-Barmatz, V.; Krelin, Y.; Shteinfer-Kuzmine, A. VDAC1 functions in Ca2+ homeostasis and cell life and death in health and disease. Cell Calcium. 2018, 69, 81–100. [Google Scholar] [CrossRef] [PubMed]
  22. Zhao, R.Z.; Jiang, S.; Zhang, L.; Yu, Z.B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 2019, 44, 3–15. [Google Scholar] [CrossRef] [Green Version]
  23. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1–13. [Google Scholar] [CrossRef] [Green Version]
  24. Boveris, A.; Chance, B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 1973, 134, 707–716. [Google Scholar] [CrossRef] [PubMed]
  25. Lambert, A.J.; Brand, M.D. Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem. J. 2004, 382, 511–517. [Google Scholar] [CrossRef]
  26. Brand, M.D. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic. Biol. Med. 2016, 100, 14–31. [Google Scholar] [CrossRef] [PubMed]
  27. Len, J.S.; Koh, W.S.D.; Tan, S.X. The roles of reactive oxygen species and antioxidants in cryopreservation. Biosci. Rep. 2019, 39, BSR20191601. [Google Scholar] [CrossRef] [Green Version]
  28. Mailloux, R.J. An Update on Mitochondrial Reactive Oxygen Species Production. Antioxidants 2020, 9, 472. [Google Scholar] [CrossRef]
  29. Van Houten, B.; Woshner, V.; Santos, J.H. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair 2006, 5, 145–152. [Google Scholar] [CrossRef] [PubMed]
  30. Guo, C.; Sun, L.; Chen, X.; Zhang, D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen. Res. 2013, 8, 2003–2014. [Google Scholar]
  31. Görlach, A.; Bertram, K.; Hudecova, S.; Krizanova, O. Calcium and ROS: A mutual interplay. Redox Biol. 2015, 6, 260–271. [Google Scholar] [CrossRef] [Green Version]
  32. Gordeeva, A.V.; Zvyagilskaya, R.A.; Labas, Y.A. Cross-talk between reactive oxygen species and calcium in living cells. Biochemistry 2003, 68, 1077–1080. [Google Scholar]
  33. Clapham, D.E. Calcium signaling. Cell 2007, 131, 1047–1058. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Bonora, M.; Pinton, P. The mitochondrial permeability transition pore and cancer: Molecular mechanisms involved in cell death. Front. Oncol. 2014, 4, 302. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.D.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 2007, 39, 44–84. [Google Scholar] [CrossRef] [PubMed]
  36. Javadov, S.; Karmazyn, M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem. 2007, 20, 1–22. [Google Scholar] [CrossRef]
  37. Hurst, S.; Hoek, J.; Sheu, S.S. Mitochondrial Ca2+ and regulation of the permeability transition pore. J. Bioenerg. Biomembr. 2017, 49, 27–47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Kantrow, S.P.; Piantadosi, C.A. Release of cytochrome c from liver mitochondria during permeability transition. Biochem Biophys Res. Commun. 1997, 232, 669–671. [Google Scholar] [CrossRef]
  39. Kim, J.S.; He, L.; Lemasters, J.J. Mitochondrial permeability transition: A common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 2003, 304, 463–470. [Google Scholar] [CrossRef]
  40. Susin, S.A.; Lorenzo, H.K.; Zamzami, N.; Marzo, I.; Snow, B.E.; Brothers, G.M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397, 441–446. [Google Scholar] [CrossRef] [PubMed]
  41. Davies, A.M.; Hershman, S.; Stabley, G.J.; Hoek, J.B.; Peterson, J.; Cahill, A. A Ca2+-induced mitochondrial permeability transition causes complete release of rat liver endonuclease G activity from its exclusive location within the mitochondrial intermembrane space. Identification of a novel endo-exonuclease activity residing within the mitochondrial matrix. Nucleic Acids. Res. 2003, 31, 1364–1373. [Google Scholar] [PubMed] [Green Version]
  42. Ankel-Simons, F.; Cummins, M.J. Misconceptions about mitochondria and mammalian fertilization: Implications for theories on human evolution. PNAS 1996, 93, 13859–13863. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Rajender, S.; Rahul, P.; Ali Mahdi, A. Mitochondria, spermatogenesis and male infertility. Mitochondrion 2010, 10, 419–428. [Google Scholar] [CrossRef] [PubMed]
  44. Agarwal, A.; Cocuzza, M.; Abdelrazik, H.; Sharma, R. Oxidative stress measurement in patients with male or female factor infertility. In Handbook of Chemiluminescent Methods in Oxidative Stress Assessment; Popov, I., Lewin, G., Eds.; Transworld Research Network: Kerala, India, 2009; pp. 195–218. [Google Scholar]
  45. Durairajanayagam, D.; Singh, D.; Agarwal, A.; Henkel, R. Causes and consequences of sperm mitochondrial dysfunction. Andrologia 2020, 53, e13666. [Google Scholar] [CrossRef]
  46. Park, Y.J.; Pang, M.G. Mitochondrial functionality in male fertility: From spermatogenesis to fertilization. Antioxidants 2021, 10, 98. [Google Scholar] [CrossRef] [PubMed]
  47. Darr, C.R.; Cortopassi, G.A.; Datta, S.; Varner, D.D.; Meyers, S.A. Mitochondrial oxygen consumption is a unique indicator of stallion spermatozoal health and varies with cryopreservation media. Theriogenology. 2016, 86, 1382–1392. [Google Scholar] [CrossRef] [PubMed]
  48. Losano, J.D.A.; Padín, J.F.; Méndez-López, I.; Angrimani, D.S.R.; García, A.G.; Barnabe, V.H.; Nichi, M. The stimulated glycolytic pathway is able to maintain ATP levels and kinetic patterns of bovine epididymal sperm subjected to mitochondrial uncoupling. Oxid. Med. Cell. Longev. 2017, 2017, 1682393. [Google Scholar] [CrossRef]
  49. Hu, C.H.; Zhuang, X.J.; Wei, Y.M.; Zhang, M.; Lu, S.S.; Lu, Y.Q.; Yang, X.G.; Lu, K.H. Comparison of mitochondrial function in boar and bull spermatozoa throughout cryopreservation based on JC-1 staining. Cryo Lett. 2017, 38, 75–79. [Google Scholar]
  50. Paoli, D.; Gallo, M.; Rizzo, F.; Baldi, E.; Francavilla, S.; Lenzi, A.; Lombardo, F.; Gandini, L. Mitochondrial membrane potential profile and its correlation with increasing sperm motility. Fertil Steril. 2011, 95, 2315–2319. [Google Scholar] [CrossRef]
  51. Ferramosca, A.; Provenzano, S.P.; Coppola, L.; Zara, V. Mitochondrial respiratory efficiency is positively correlated with human sperm motility. Urology 2012, 79, 809–814. [Google Scholar] [CrossRef]
  52. Kasai, T.; Ogawa, K.; Mizuno, K.; Nagai, S.; Uchida, Y.; Ohta, S.; Fujie, M.; Suzuki, K.; Hirata, S.; Hoshi, K. Relationship between sperm mitochondrial membrane potential, sperm motility, and fertility potential. Asian J. Androl. 2002, 4, 97–103. [Google Scholar]
  53. Sousa, A.P.; Amaral, A.; Baptista, M.; Tavares, R.; Caballero Campo, P.; Caballero Peregrin, P.; Freitas, A.; Paiva, A.; Almeida-Santos, T.; Ramalho-Santos, J. Not all sperm are equal: Functional mitochondria characterize a subpopulation of human sperm with better fertilization potential. PLoS ONE 2011, 6, e18112. [Google Scholar] [CrossRef] [Green Version]
  54. Marchetti, P.; Ballot, C.; Jouy, N.; Thomas, P.; Marchetti, C. Influence of mitochondrial membrane potential of spermatozoa on in vitro fertilisation outcome. Andrologia 2012, 44, 136–141. [Google Scholar] [CrossRef]
  55. Malic Voncina, S.; Golob, B.; Ihan, A.; Kopitar, A.N.; Kolbezen, M.; Zorn, B. Sperm DNA fragmentation and mitochondrial membrane potential combined are better for predicting natural conception than standard sperm parameters. Fertil. Steril. 2016, 105, 637–644.e1. [Google Scholar] [CrossRef] [Green Version]
  56. Zhang, G.; Yang, W.; Zou, P.; Jiang, F.; Zeng, Y.; Chen, Q.; Sun, L.; Yang, H.; Zhou, N.; Wang, X.; et al. Mitochondrial functionality modifies human sperm acrosin activity, acrosome reaction capability and chromatin integrity. Hum. Reprod. 2019, 34, 3–11. [Google Scholar] [CrossRef]
  57. Reynier, P.; Chrétien, M.F.; Savagner, F.; Larcher, G.; Rohmer, V.; Barrière, P.; Malthièry, Y. Long PCR analysis of human gamete mtDNA suggests defective mitochondrial maintenance in spermatozoa and supports the bottleneck theory for oocytes. Biochem. Biophys. Res. Commun. 1998, 252, 373–377. [Google Scholar] [CrossRef] [PubMed]
  58. Venkatesh, S.; Deecaraman, M.; Kumar, R.; Shamsi, M.B.; Dada, R. Role of reactive oxygen species in the pathogenesis of mitochondrial DNA (mtDNA) mutations in male infertility. Indian J. Med. Res. 2009, 129, 127–137. [Google Scholar]
  59. Kumar, D.P.; Sangeetha, N. Mitochondrial DNA mutations and male infertility. Indian, J. Hum. Genet. 2009, 15, 93–97. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. May-Panloup, P.; Chretien, M.F.; Savagner, F.; Vasseur, C.; Jean, M.; Malthiery, Y.; Reynier, P. Increased sperm mitochondrial DNA content in male infertility. Hum. Reprod. 2003, 18, 550–556. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Song, G.J.; Lewis, V. Mitochondrial DNA integrity and copy number in sperm from infertile men. Fert Steril. 2008, 90, 2238–2244. [Google Scholar] [CrossRef]
  62. Rosati, A.J.; Whitcomb, B.W.; Brandon, N.; Buck Louis, G.M.; Mumford, S.L.; Schisterman, E.F.; Pilsner, J.R. Sperm mitochondrial DNA biomarkers and couple fecundity. Hum. Reprod. 2020, 35, 2619–2625. [Google Scholar] [CrossRef] [PubMed]
  63. Tiegs, A.W.; Tao, X.; Landis, J.; Zhan, Y.; Franasiak, J.M.; Seli, E.; Wells, D.; Fragouli, E.; Scott, R.T., Jr. Sperm mitochondrial DNA copy number is not a predictor of intracytoplasmic sperm injection (ICSI) cycle outcomes. Reprod. Sci. 2020, 27, 1350–1356. [Google Scholar] [CrossRef] [PubMed]
  64. Moraes, C.R.; Meyers, S. The sperm mitochondrion: Organelle of many functions. Anim. Reprod. Sci. 2018, 194, 71–80. [Google Scholar] [CrossRef]
  65. Buzadzic, B.; Vucetic, M.; Jankovic, A.; Stancic, A.; Korac, A.; Korac, B.; Otasevic, V. New insights into male (in)fertility: The importance of NO. Br. J. Pharmacol. 2015, 172, 1455–1467. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Agarwal, A.; Prabakaran, S.A.; Said, T.M. Prevention of oxidative stress injury to sperm. J. Androl. 2005, 26, 654–660. [Google Scholar] [CrossRef] [PubMed]
  67. Wathes, D.C.; Abayasekara, D.R.; Aitken, R.J. Polyunsaturated fatty acids in male and female reproduction. Biol. Reprod. 2007, 77, 190–201. [Google Scholar] [CrossRef]
  68. Walters, J.L.H.; De Iuliis, G.N.; Nixon, B.; Bromfield, E.G. Oxidative stress in the male germline: A review of novel strategies to reduce 4-hydroxynonenal production. Antioxidants 2018, 7, 132. [Google Scholar] [CrossRef] [Green Version]
  69. Aitken, R.J.; Gibb, Z.; Mitchell, L.A.; Lambourne, S.R.; Connaughton, H.S.; De Iuliis, G.N. Sperm motility is lost in vitro as a consequence of mitochondrial free radical production and the generation of electrophilic aldehydes but can be significantly rescued by the presence of nucleophilic thiols. Biol. Reprod. 2012, 87, 110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Aitken, R.J.; Whiting, S.; De Iuliis, G.N.; McClymont, S.; Mitchell, L.A.; Baker, M.A. Electrophilic aldehydes generated by sperm metabolism activate mitochondrial reactive oxygen species generation and apoptosis by targeting succinate dehydrogenase. J. Biol. Chem. 2012, 287, 33048–33060. [Google Scholar] [CrossRef] [Green Version]
  71. Aitken, R.J.; Drevet, J.R. The Importance of Oxidative Stress in Determining the Functionality of Mammalian Spermatozoa: A Two-Edged Sword. Antioxidants 2020, 9, 111. [Google Scholar] [CrossRef] [Green Version]
  72. Abush, A.; Hauser, R.; Paz, G.; Kleiman, S.E.; Lehavi, O.; Yavetz, H.; Yogev, L. Thawed human sperm quality is influenced by the volume of the cryopreserved specimen. Fertil. Steril. 2014, 101, 640–646. [Google Scholar] [CrossRef] [PubMed]
  73. Kopeika, J.; Thornhill, A.; Khalaf, Y. The effect of cryopreservation on the genome of gametes and embryos: Principles of cryobiology and critical appraisal of the evidence. Hum. Reprod. Update 2015, 21, 209–227. [Google Scholar] [CrossRef] [Green Version]
  74. Najafi, A.; Asadi, E.; Moawad, A.R.; Mikaeili, S.; Amidi, F.; Adutwum, E.; Safa, M.; Sobhani, A.G. Supplementation of freezing and thawing media with brain-derived neurotrophic factor protects human sperm from freeze-thaw-induced damage. Fertil. Steril. 2016, 106, 1658–1665.e4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Paoli, D.; Pelloni, M.; Lenzi, A.; Lombardo, F. Cryopreservation of sperm: Effects on chromatin and strategies to prevent them. Adv. Exp. Med. Biol. 2019, 1166, 149–167. [Google Scholar] [PubMed]
  76. Kumar, A.; Prasad, J.K.; Srivastava, N.; Ghosh, S.K. Strategies to Minimize Various Stress-Related Freeze-Thaw Damages During Conventional Cryopreservation of Mammalian Spermatozoa. Biopreserv. Biobank 2019, 17, 603–612. [Google Scholar] [CrossRef] [PubMed]
  77. Eva Mocé, A.J.F.; Graham James, K. Human sperm cryopreservation. EMJ Eur. Med J. 2016, 1, 86–91. [Google Scholar]
  78. Degl’Innocenti, S.; Filimberti, E.; Magini, A.; Krausz, C.; Lombardi, G.; Fino, M.G.; Rastrelli, G.; Maggi, M.; Baldi, E. Semen cryopreservation for men banking for oligospermia, cancers, and other pathologies: Prediction of post-thaw outcome using basal semen quality. Fertil. Steril. 2013, 100, 1555–1563.e1-3. [Google Scholar]
  79. Oehninger, S.; Duru, N.K.; Srisombut, C.; Morshedi, M. Assessment of sperm cryodamage and strategies to improve outcome. Mol. Cell. Endocrinol. 2000, 169, 3–10. [Google Scholar] [CrossRef]
  80. Kalthur, G.; Adiga, S.K.; Upadhya, D.; Rao, S.; Kumar, P. Effect of cryopreservation on sperm DNA integrity in patients with teratospermia. Fertil. Steril. 2008, 89, 1723–1727. [Google Scholar] [CrossRef]
  81. Brugnon, F.; Ouchchane, L.; Pons-Rejraji, H.; Artonne, C.; Farigoule, M.; Janny, L. Density gradient centrifugation prior to cryopreservation and hypotaurine supplementation improve post-thaw quality of sperm from infertile men with oligoasthenoteratozoospermia. Hum. Reprod. 2013, 28, 2045–2057. [Google Scholar] [CrossRef]
  82. Gualtieri, R.; Barbato, V.; Fiorentino, I.; Braun, S.; Rizos, D.; Longobardi, S.; Talevi, R. Treatment with zinc, d-aspartate, and coenzyme Q10 protects bull sperm against damage and improves their ability to support embryo development. Theriogenology 2014, 82, 592–598. [Google Scholar] [CrossRef] [PubMed]
  83. Lane, M.; McPherson, N.O.; Fullston, T.; Spillane, M.; Sandeman, L.; Kang, W.X.; Zander-Fox, D.L. Oxidative stress in mouse sperm impairs embryo development, fetal growth and alters adiposity and glucose regulation in female offspring. PLoS ONE 2014, 9, e100832. [Google Scholar] [CrossRef] [Green Version]
  84. Barbato, V.; Talevi, R.; Braun, S.; Merolla, A.; Sudhakaran, S.; Longobardi, S.; Gualtieri, R. Supplementation of sperm media with zinc, D-aspartate and co-enzyme Q10 protects bull sperm against exogenous oxidative stress and improves their ability to support embryo development. Zygote 2017, 25, 168–175. [Google Scholar] [CrossRef]
  85. Ribas-Maynou, J.; Yeste, M.; Salas-Huetos, A. The relationship between sperm oxidative stress alterations and IVF/ICSI outcomes: A systematic review from nonhuman mammals. Biology 2020, 9, 178. [Google Scholar] [CrossRef] [PubMed]
  86. Ezzati, M.; Shanehbandi, D.; Hamdi, K.; Rahbar, S.; Pashaiasl, M. Influence of cryopreservation on structure and function of mammalian spermatozoa: An overview. Cell Tissue Bank 2020, 21, 1–15. [Google Scholar] [CrossRef] [PubMed]
  87. Said, T.M.; Gaglani, A.; Agarwal, A. Implication of apoptosis in sperm cryoinjury. Reprod. Biomed. Online 2010, 21, 456–462. [Google Scholar] [CrossRef] [Green Version]
  88. Salamon, S.; Maxwell, W.M.C. Frozen storage of ram semen I. Processing, freezing, thawing and fertility after cervical insemination. Anim. Reprod. Sci. 1995, 37, 185–249. [Google Scholar] [CrossRef]
  89. Ortega Ferrusola, C.; González Fernández, L.; Salazar Sandoval, C.; Macías García, B.; Rodríguez Martínez, H.; Tapia, J.A.; Peña, F.J. Inhibition of the mitochondrial permeability transition pore reduces "apoptosis like" changes during cryopreservation of stallion spermatozoa. Theriogenology 2010, 74, 458–465. [Google Scholar] [CrossRef] [PubMed]
  90. Treulen, F.; Arias, M.E.; Aguila, L.; Uribe, P.; Felmer, R. Cryopreservation induces mitochondrial permeability transition in a bovine sperm model. Cryobiology 2018, 83, 65–74. [Google Scholar] [CrossRef] [PubMed]
  91. Fang, Y.; Zhao, C.; Xiang, H.; Zhao, X.; Zhong, R. Melatonin inhibits formation of mitochondrial permeability transition pores and improves oxidative phosphorylation of frozen-thawed ram sperm. Front. Endocrinol. 2020, 10, 896. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Fang, Y.; Zhao, C.; Xiang, H.; Jia, G.; Zhong, R. Melatonin improves cryopreservation of ram sperm by inhibiting mitochondrial permeability transition pore opening. Reprod. Domest. Anim. 2020, 55, 1240–1249. [Google Scholar] [CrossRef] [PubMed]
  93. Tan, D.X.; Manchester, L.C.; Qin, L.; Reiter, R.J. Melatonin: A mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int. J. Mol. Sci. 2016, 17, 2124. [Google Scholar] [CrossRef]
  94. Succu, S.; Berlinguer, F.; Pasciu, V.; Satta, V.; Leoni, G.G.; Naitana, S. Melatonin protects ram spermatozoa from cryopreservation injuries in a dose-dependent manner. J. Pineal. Res. 2011, 50, 310–318. [Google Scholar] [CrossRef]
  95. Deng, S.L.; Sun, T.C.; Yu, K.; Wang, Z.P.; Zhang, B.L.; Zhang, Y.; Wang, X.X.; Lian, Z.X.; Liu, Y.X. Melatonin reduces oxidative damage and upregulates heat shock protein 90 expression in cryopreserved human semen. Free Radic. Biol. Med. 2017, 113, 347–354. [Google Scholar] [CrossRef]
  96. Najafi, A.; Adutwum, E.; Yari, A.; Salehi, E.; Mikaeili, S.; Dashtestani, F.; Abolhassani, F.; Rashki, L.; Shiasi, S.; Asadi, E. Melatonin affects membrane integrity, intracellular reactive oxygen species, caspase3 activity and AKT phosphorylation in frozen thawed human sperm. Cell Tissue Res. 2018, 372, 149–159. [Google Scholar] [CrossRef] [PubMed]
  97. Pariz, J.R.; Ranéa, C.; Monteiro, R.A.C.; Evenson, D.P.; Drevet, J.R.; Hallak, J. Melatonin and Caffeine Supplementation Used, Respectively, as Protective and Stimulating Agents in the Cryopreservation of Human Sperm Improves Survival, Viability, and Motility after Thawing compared to Traditional TEST-Yolk Buffer. Oxid. Med. Cell. Longev. 2019, 2019, 6472945. [Google Scholar] [CrossRef]
  98. Wang, J.Y.; Li, J.Q.; Xiao, Y.M.; Fu, B.; Qin, Z.H. Triphenylphosphonium (TPP)-based antioxidants: A new perspective on antioxidant design. ChemMedChem 2020, 15, 404–410. [Google Scholar] [CrossRef]
  99. Trnka, J.; Blaikie, F.H.; Smith, R.A.; Murphy, M.P. A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. Free Radic. Biol. Med. 2008, 44, 1406–1419. [Google Scholar] [CrossRef] [PubMed]
  100. Lu, X.; Zhang, Y.; Bai, H.; Liu, J.; Li, J.; Wu, B. Mitochondria-targeted antioxidant MitoTEMPO improves the post-thaw sperm quality. Cryobiology 2018, 80, 26–29. [Google Scholar] [CrossRef] [PubMed]
  101. Zhang, X.; Lu, X.; Li, J.; Xia, Q.; Gao, J.; Wu, B. Mito-Tempo alleviates cryodamage by regulating intracellular oxidative metabolism in spermatozoa from asthenozoospermic patients. Cryobiology 2019, 91, 18–22. [Google Scholar] [CrossRef]
  102. Ross, M.F.; Prime, T.A.; Abakumova, I.; James, A.M.; Porteous, C.M.; Smith, R.A.; Murphy, M.P. Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochem. J. 2008, 411, 633–645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Fang, L.; Bai, C.; Chen, Y.; Dai, J.; Xiang, Y.; Ji, X.; Huang, C.; Dong, Q. Inhibition of ROS production through mitochondria-targeted antioxidant and mitochondrial uncoupling increases post-thaw sperm viability in yellow catfish. Cryobiology 2014, 69.3, 386–393. [Google Scholar] [CrossRef] [PubMed]
  104. Liu, L.; Wang, M.J.; Yu, T.H.; Cheng, Z.; Li, M.; Guo, Q.W. Mitochondria-targeted antioxidant Mitoquinone protects post-thaw human sperm against oxidative stress injury. Zhonghua Nan Ke Xue 2016, 22, 205–211. [Google Scholar]
  105. Szeto, H.H. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br. J. Pharmacol. 2014, 171, 2029–2050. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  106. Kagan, V.E.; Bayir, H.A.; Belikova, N.A.; Kapralov, O.; Tyurina, Y.Y.; Tyurin, V.A.; Jiang, J.; Stoyanovsky, D.A.; Wipf, P.; Kochanek, P.M.; et al. Cytochrome c/cardiolipin relations in mitochondria: A kiss of death. Free Radic. Biol. Med. 2009, 46, 1439–1453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Ren, M.; Phoon, C.K.; Schlame, M. Metabolism and function of mitochondrial cardiolipin. Prog. Lipid Res. 2014, 55, 1–16. [Google Scholar] [CrossRef]
  108. Lu, Y.W.; Claypool, S.M. Disorders of phospholipid metabolism: An emerging class of mitochondrial disease due to defects in nuclear genes. Front. Genet. 2015, 6, 3. [Google Scholar] [CrossRef] [PubMed]
  109. Ren, M.; Xu, Y.; Erdjument-Bromage, H.; Donelian, A.; Phoon, C.K.L.; Terada, N.; Strathdee, D.; Neubert, T.A.; Schlame, M. Extramitochondrial cardiolipin suggests a novel function of mitochondria in spermatogenesis. J. Cell Biol. 2019, 218, 1491–1502. [Google Scholar] [CrossRef]
  110. Bai, H.; Zhang, Y.; Tian, S.; Hu, R.; Liang, Y.; Gao, J.; Wang, Y.; Wu, B. Elamipretide as a potential candidate for relieving cryodamage to human spermatozoa during cryopreservation. Cryobiology 2020, 95, 138–142. [Google Scholar] [CrossRef] [PubMed]
  111. Ferreira, G.; Costa, C.; Bassaizteguy, V.; Santos, M.; Cardozo, R.; Montes, J.; Settineri, R.; Nicolson, G.L. Incubation of human sperm with micelles made from glycerophospholipid mixtures increases sperm motility and resistance to oxidative stress. PLoS ONE 2018, 13, e0197897. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Miyazawa, T.; Burdeos, G.C.; Itaya, M.; Nakagawa, K.; Miyazawa, T. Vitamin E: Regulatory redox interactions. IUBMB Life 2019, 71, 430–441. [Google Scholar] [CrossRef]
  113. Zhu, Z.; Fan, X.; Lv, Y.; Zhang, N.; Fan, C.; Zhang, P.; Zeng, W. Vitamin E analogue improves rabbit sperm quality during the process of cryopreservation through its antioxidative action. PLoS ONE 2015, 10, e0145383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Taylor, K.; Roberts, P.; Sanders, K.; Burton, P. Effect of antioxidant supplementation of cryopreservation medium on post-thaw integrity of human spermatozoa. Reprod. Biomed. Online 2009, 18, 184–189. [Google Scholar] [CrossRef]
  115. Kalthur, G.; Raj, S.; Thiyagarajan, A.; Kumar, S.; Kumar, P.; Adiga, S.K. Vitamin E supplementation in semen-freezing medium improves the motility and protects sperm from freeze-thaw-induced DNA damage. Fertil. Steril. 2011, 95, 1149–1151. [Google Scholar] [CrossRef] [PubMed]
  116. Safa, S.; Moghaddam, G.; Jozani, R.J.; Daghigh Kia, H.; Janmohammadi, H. Effect of vitamin E and selenium nanoparticles on post-thaw variables and oxidative status of rooster semen. Anim. Reprod. Sci. 2016, 174, 100–106. [Google Scholar] [CrossRef] [PubMed]
  117. Moghbeli, M.; Kohram, H.; Zare-Shahaneh, A.; Zhandi, M.; Sharideh, H.; Sharafi, M. Effect of sperm concentration on characteristics and fertilization capacity of rooster sperm frozen in the presence of the antioxidants catalase and vitamin E. Theriogenology 2016, 86, 1393–1398. [Google Scholar] [CrossRef]
  118. Khellouf, A.; Benhenia, K.; Fatami, S.; Iguer-Ouada, M. The complementary effect of cholesterol and vitamin E preloaded in cyclodextrins on frozen bovine semen: Motility parameters, membrane integrity and lipid peroxidation. Cryo Lett. 2018, 39, 113–120. [Google Scholar]
  119. Satorre, M.M.; Breininger, E.; Cetica, P.D.; Córdoba, M. Relation between respiratory activity and sperm parameters in boar spermatozoa cryopreserved with alpha-tocopherol and selected by Sephadex. Reprod. Domest. Anim. 2018, 53, 979–985. [Google Scholar] [CrossRef] [PubMed]
  120. Zerbinati, C.; Caponecchia, L.; Fiori, C.; Sebastianelli, A.; Salacone, P.; Ciacciarelli, M.; Iuliano, L. Alpha- and gamma-tocopherol levels in human semen and their potential functional implications. Andrologia 2020, 17, e13543. [Google Scholar] [CrossRef]
  121. Sánchez-Rubio, F.; Soria-Meneses, P.J.; Jurado-Campos, A.; Bartolomé-García, J.; Gómez-Rubio, V.; Soler, A.J.; Arroyo-Jimenez, M.M.; Santander-Ortega, M.J.; Plaza-Oliver, M.; Lozano, M.V.; et al. Nanotechnology in reproduction: Vitamin E nanoemulsions for reducing oxidative stress in sperm cells. Free Radic. Biol. Med. 2020, 160, 47–56. [Google Scholar] [CrossRef]
  122. Agarwal, A.; Said, T.M. Carnitines and male infertility. Reprod. Biomed. 2004, 8, 376–384. [Google Scholar] [CrossRef]
  123. Zhang, W.; Li, F.; Cao, H.; Li, C.; Du, C.; Yao, L.; Mao, H.; Lin, W. Protective effects of l-carnitine on astheno- and normozoospermic human semen samples during cryopreservation. Zygote 2016, 24, 293–300. [Google Scholar] [CrossRef] [PubMed]
  124. Song, W.H.; Oman Ballard, J.W.; Yi, Y.J.; Sutovsky, P. Regulation of mitochondrial genome inheritance by autophagy and ubiquitin-proteasome system: Implications for health, fitness, and fertility. Biomed. Res. Int. 2014, 2014, 981867. [Google Scholar] [CrossRef] [Green Version]
  125. Wright, A.F.; Murphy, M.P.; Turnbull, D.M. Do organellar genomes function as long-term redox damage sensors? Trends Genet. 2009, 25, 253–261. [Google Scholar] [CrossRef]
  126. Wai, T.; Teoli, D.; Shoubridge, E.A. The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat. Genet. 2008, 40, 1484–1488. [Google Scholar] [CrossRef] [PubMed]
  127. Wai, T.; Ao, A.; Zhang, X.; Cyr, D.; Dufort, D.; Shoubridge, E.A. The role of mitochondrial DNA copy number in mammalian fertility. Biol. Reprod. 2010, 83, 52–62. [Google Scholar] [CrossRef] [Green Version]
  128. Reynier, P.; May-Panloup, P.; Chretien, M.-F.; Morgan, C.J.; Jean, M.; Savagner, F.; Barrière, P.; Malthièry, Y. Mitochondrial DNA content affects the fertilizability of human oocytes. Mol. Hum. Reprod. 2001, 7, 425–429. [Google Scholar] [CrossRef] [Green Version]
  129. Eichenlaub-Ritter, U.; Wieczorek, M.; Luke, S.; Seidel, T. Age related changes in mitochondrial function and new approaches to study redox regulation in mammalian oocytes in response to age or maturation conditions. Mitochondrion 2011, 11, 783–796. [Google Scholar] [CrossRef]
  130. Van Blerkom, J. Mitochondria in early mammalian development. Semin. Cell. Dev. Biol. 2009, 20, 354–364. [Google Scholar] [CrossRef] [PubMed]
  131. Lima, A.; Burgstaller, J.; Sanchez-Nieto, J.M.; Rodríguez, T.A. The Mitochondria and the Regulation of Cell Fitness During Early Mammalian Development. Curr. Top. Dev. Biol. 2018, 128, 339–363. [Google Scholar] [PubMed]
  132. Trimarchi, J.R.; Liu, L.; Porterfield, D.M.; Smith, P.J.; Keefe, D.L. Oxidative phosphorylation-dependent and -independent oxygen consumption by individual preimplantation mouse embryos. Biol. Reprod. 2000, 62, 1866–1874. [Google Scholar] [CrossRef]
  133. Motta, P.; Nottola, S.; Makabe, S.; Heyn, R. Mitochondrial morphology in human fetal and adult female germ cells. Hum. Reprod. 2000, 15, 128–147. [Google Scholar] [CrossRef] [PubMed]
  134. Nagano, M.; Katagiri, S.; Takahashi, Y. ATP content and maturational/developmental ability of bovine oocytes with various cytoplasmic morphologies. Zygote 2006, 14, 299–304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  135. Van Blerkom, J.; Davis, P. Mitochondrial signaling and fertilization. Mol. Hum. Reprod. 2007, 13, 759–770. [Google Scholar] [CrossRef] [Green Version]
  136. Duran, H.E.; Simsek-Duran, F.; Oehninger, S.C.; Jones, H.W., Jr.; Castora, F.J. The association of reproductive senescence with mitochondrial quantity, function, and DNA integrity in human oocytes at different stages of maturation. Fertil. Steril. 2011, 96, 384–388. [Google Scholar] [CrossRef]
  137. Stojkovic, M.; Machado, S.A.; Stojkovic, P.; Zakhartchenko, V.; Hutzler, P.; Gonçalves, P.B.; Wolf, E. Mitochondrial distribution and adenosine triphosphate content of bovine oocytes before and after in vitro maturation: Correlation with morphological criteria and developmental capacity after in vitro fertilization and culture. Biol. Reprod. 2001, 64, 904–909. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  138. Van Blerkom, J. Mitochondrial function in the human oocyte and embryo and their role in developmental competence. Mitochondrion 2011, 11, 797–813. [Google Scholar] [CrossRef] [PubMed]
  139. Dumollard, R.; Marangos, P.; Fitzharris, G.; Swann, K.; Duchen, M.; Carroll, J. Sperm-triggered [Ca2+] oscillations and Ca2+ homeostasis in the mouse egg have an absolute requirement for mitochondrial ATP production. Development 2004, 131, 3057–3067. [Google Scholar] [CrossRef] [Green Version]
  140. Van Blerkom, J.; Davis, P.; Mawhig, V.; Alexander, S. Domains of high and low polarized mitochondria in mouse and human oocytes and early embryos. Hum. Reprod. 2002, 17, 393–406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  141. Warburg, O. Beobachtungen uber die oxydationsprozesse im seeigelei. Hoppe Seylers Z. Physiol. Chem. 1908, 57, 1–16. [Google Scholar] [CrossRef]
  142. Schatten, H.; Sun, Q.Y.; Prather, R. The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility. Reprod. Biol. Endocrinol. 2014, 12, 111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  143. Di Emidio, G.; Santini, S.J.; D’Alessandro, A.M.; Vetuschi, A.; Sferra, R.; Artini, P.G.; Carta, G.; Falone, S.; Amicarelli, F.; Tatone, C. SIRT1 participates in the response to methylglyoxal-dependent glycative stress in mouse oocytes and ovary. Biochim. Biophys. Acta Mol. Basis Dis. 2019, 1865, 1389–1401. [Google Scholar] [CrossRef]
  144. Lord, T.; Aitken, R.J. Oxidative stress and ageing of the post-ovulatory oocyte. Reproduction 2013, 146, R217–R227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Shamsi, M.B.; Govindaraj, P.; Chawla, L.; Malhotra, N.; Singh, N.; Mittal, S.; Talwar, P.; Thangaraj, K.; Dada, R. Mitochondrial DNA variations in ova and blastocyst: Implications in assisted reproduction. Mitochondrion 2013, 13, 96–105. [Google Scholar] [CrossRef] [PubMed]
  146. Fragouli, E.; Spath, K.; Alfarawati, S.; Kaper, F.; Craig, A.; Michel, C.E.; Kokocinski, F.; Cohen, J.; Munne, S.; Wells, D. Altered levels of mitochondrial DNA are associated with female age, aneuploidy, and provide an independent measure of embryonic implantation potential. PLoS Genet. 2015, 11, e1005241. [Google Scholar] [CrossRef] [PubMed]
  147. Sasaki, H.; Hamatani, T.; Kamijo, S.; Iwai, M.; Kobanawa, M.; Ogawa, S.; Miyado, K.; Tanaka, M. Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence. Front. Endocrinol. 2019, 10, 811. [Google Scholar]
  148. Eichenlaub-Ritter, U.; Vogt, E.; Yin, H.; Gosden, R. Spindles, mitochondria and redox potential in ageing oocytes. Reprod. Biomed. Online 2004, 8, 45–58. [Google Scholar] [CrossRef]
  149. Mikwar, M.; MacFarlane, A.J.; Marchetti, F. Mechanisms of oocyte aneuploidy associated with advanced maternal age. Mutat. Res. 2020, 785, 108320. [Google Scholar] [CrossRef] [PubMed]
  150. Lim, J.; Luderer, U. Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary. Biol. Reprod. 2011, 84, 775–782. [Google Scholar] [CrossRef] [Green Version]
  151. Simsek-Duran, F.; Li, F.; Ford, W.; Swanson, R.J.; Jones, H.W.; Castora, F.J. Age associated metabolic and morphologic changes in mitochondria of individual mouse and hamster oocytes. PLoS ONE 2013, 8, e64955. [Google Scholar] [CrossRef] [Green Version]
  152. Takeo, S.; Goto, H.; Kuwayama, T.; Monji, Y.; Iwata, H. Effect of maternal age on the ratio of cleavage and mitochondrial DNA copy number in early developmental stage bovine embryos. J. Reprod. Dev. 2013, 59, 174–179. [Google Scholar] [CrossRef] [Green Version]
  153. Cree, L.M.; Hammond, E.R.; Shelling, A.N.; Berg, M.C.; Peek, J.C.; Green, M.P. Maternal age and ovarian stimulation independently affect oocyte mtDNA copy number and cumulus cell gene expression in bovine clones. Hum. Reprod. 2015, 30, 1410–1420. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  154. Fragouli, E.; McCaffrey, C.; Ravichandran, K.; Spath, K.; Grifo, J.A.; Munné, S.; Wells, D. Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: A blinded prospective non-selection study. Hum. Reprod. 2017, 32, 2340–2347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  155. Thouas, G.A.; Trounson, A.O.; Wolvetang, E.J.; Jones, G.M. Mitochondrial dysfunction in mouse oocytes results in preimplantation embryo arrest in vitro. Biol. Reprod. 2004, 71, 1936–1942. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  156. Labarta, E.; de Los Santos, M.J.; Escribá, M.J.; Pellicer, A.; Herraiz, S. Mitochondria as a tool for oocyte rejuvenation. Fertil. Steril. 2019, 111, 219–226. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  157. Smeets, H.J.M. Preventing the transmission of mitochondrial DNA disorders: Selecting the good guys or kicking out the bad guys. Reprod. BioMed Online 2013, 27, 599–610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  158. Amato, P.; Tachibana, M.; Sparman, M.; Mitalipov, S. Three-parent in vitro fertilization: Gene replacement for the prevention of inherited mitochondrial diseases. Fertil. Steril. 2014, 101, 31–35. [Google Scholar] [CrossRef] [Green Version]
  159. Mitalipov, S.; Wolf, D.P. Clinical and ethical implications of mitochondrial gene transfer. Trends Endocrinol. Metab. 2014, 25, 5–7. [Google Scholar] [CrossRef] [Green Version]
  160. Cohen, J.; Scott, R.; Alikani, M.; Schimmel, T.; Munne, S.; Levron, J.; Wu, L.; Brenner, C.; Warner, C.; Willadsen, S. Ooplasmic transfer in mature human oocytes. Mol. Hum. Reprod. 1998, 4, 269–280. [Google Scholar] [CrossRef] [PubMed]
  161. Lanzendorf, S.E.; Mayer, J.F.; Toner, J.; Oehninger, S.; Saffan, D.S.; Muasher, S. Pregnancy following transfer of ooplasm from cryopreserved-thawed donor oocytes into recipient oocytes. Fertil. Steril. 1999, 71, 575–577. [Google Scholar] [CrossRef]
  162. Barritt, J.A.; Brenner, C.A.; Malter, H.E.; Cohen, J. Mitochondria in human offspring derived from ooplasmic transplantation. Hum. Reprod. 2001, 16, 513–516. [Google Scholar] [CrossRef]
  163. Mobarak, H.; Heidarpour, M.; Tsai, P.J.; Rezabakhsh, A.; Rahbarghazi, R.; Nouri, M.; Mahdipour, M. Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging. Cell Biosci. 2019, 9, 95. [Google Scholar] [CrossRef] [PubMed]
  164. Potdar, N.; Gelbaya, T.A.; Nardo, L.G. Oocyte vitrification in the 21st century and post-warming fertility outcomes: A systematic review and meta-analysis. Reprod. Biomed. Online 2014, 29, 159–176. [Google Scholar] [CrossRef] [Green Version]
  165. Glujovsky, D.; Riestra, B.; Sueldo, C.; Fiszbajn, G.; Repping, S.; Nodar, F.; Papier, S.; Ciapponi, A. Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database Syst. Rev. 2014, 5, CD010047. [Google Scholar] [CrossRef]
  166. Kool, E.M.; Bos, A.M.E.; van der Graaf, R.; Fauser, B.C.J.M.; Bredenoord, A.L. Ethics of oocyte banking for third-party assisted reproduction: A systematic review. Hum. Reprod. Update 2018, 24, 615–635. [Google Scholar] [CrossRef]
  167. Chen, C. Pregnancy after human oocyte cryopreservation. Lancet 1986, 1, 884–886. [Google Scholar] [CrossRef]
  168. Van Uem, J.F.; Siebzehnrubl, E.R.; Schuh, B.; Koch, R.; Trotnow, S.; Lang, N. Birth after cryopreservation of unfertilized oocytes. Lancet 1987, 1, 752–753. [Google Scholar] [CrossRef]
  169. Kuwayama, M.; Vajta, G.; Kato, O.; Leibo, S.P. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod. Biomed. Online 2005, 11, 300–308. [Google Scholar] [CrossRef]
  170. Practice Committees of American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: A guideline. Fertil. Steril. 2013, 99, 37–43. [Google Scholar] [CrossRef]
  171. Cao, Y.X.; Xing, Q.; Li, L.; Cong, L.; Zhang, Z.G.; Wei, Z.L.; Zhou, P. Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification. Fertil. Steril. 2009, 92, 1306–1311. [Google Scholar] [CrossRef] [PubMed]
  172. Smith, G.D.; Serafini, P.C.; Fioravanti, J.; Yadid, I.; Coslovsky, M.; Hassun, P.; Alegretti, J.R.; Motta, E.L. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil. Steril. 2010, 94, 2088–2095. [Google Scholar] [CrossRef] [PubMed]
  173. Cobo, A.; Diaz, C. Clinical application of oocyte vitrification: A systematic review and meta-analysis of randomized controlled trials. Fertil. Steril. 2011, 96, 277–285. [Google Scholar] [CrossRef] [PubMed]
  174. Edgar, D.H.; Gook, D.A. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum. Reprod. Update 2012, 18, 536–554. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  175. Cil, A.P.; Bang, H.; Oktay, K. Age-specific probability of live birth with oocyte cryopreservation: An individual patient data meta-analysis. Fertil. Steril. 2013, 100, 492–499. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  176. O’Connell, M.; McClure, N.; Lewis, S.E.M. The effects of cryopreservation on sperm morphology, motility and mitochondrial function. Hum. Reprod. 2002, 17, 704–709. [Google Scholar] [CrossRef]
  177. Dalcin, L.; Silva, R.C.; Paulini, F.; Silva, B.D.M.; Neves, J.P.; Lucci, C.M. Cytoskeleton structure, pattern of mitochondrial activity and ultrastructure of frozen or vitrified sheep embryos. Cryobiology 2013, 67, 137–145. [Google Scholar] [CrossRef] [Green Version]
  178. Figueroa, E.; Valdebenito, I.; Zepeda, A.B.; Figueroa, C.A.; Dumorne´, K.; Castillo, R.L.; Farias, J.G. Effects of cryopreservation on mitochondria of fish spermatozoa. Rev. Aquacult. 2017, 9, 76–87. [Google Scholar] [CrossRef]
  179. Jones, A.; Van Blerkom, J.; Davis, P.; Toledo, A.A. Cryopreservation of metaphase II human oocytes effects mitochondrial membrane potential: Implications for developmental competence. Hum. Reprod. 2004, 19, 1861–1866. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  180. Gualtieri, R.; Iaccarino, M.; Mollo, V.; Prisco, M.; Iaccarino, S.; Talevi, R. Slow cooling of human oocytes: Ultrastructural injuries and apoptotic status. Fertil. Steril. 2009, 91, 1023–1034. [Google Scholar] [CrossRef] [PubMed]
  181. Lei, T.; Guo, N.; Tan, M.H.; Li, Y.F. Effect of mouse oocyte vitrification on mitochondrial membrane potential and distribution. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2014, 34, 99–102. [Google Scholar] [CrossRef]
  182. Tatone, C.; Di Emidio, G.; Barbaro, R.; Vento, M.; Ciriminna, R.; Artini, P.G. Effects of reproductive aging and postovulatory aging on the maintenance of biological competence after oocyte vitrification: Insights from the mouse model. Theriogenology 2011, 76, 864–873. [Google Scholar] [CrossRef]
  183. Nohales-Córcoles, M.; Sevillano-Almerich, G.; Di Emidio, G.; Tatone, C.; Cobo, A.C.; Dumollard, R.; De Los Santos Molina, M.J. Impact of vitrification on the mitochondrial activity and redox homeostasis of human oocyte. Hum. Reprod. 2016, 31, 1850–1858. [Google Scholar] [CrossRef] [PubMed]
  184. Zhao, X.M.; Du, W.H.; Wang, D.; Hao, H.S.; Liu, Y.; Qin, T.; Zhu, H.B. Effect of cyclosporine pretreatment on mitochondrial function in vitrified bovine mature oocytes. Fertil. Steril. 2011, 95, 2786–2788. [Google Scholar] [CrossRef] [PubMed]
  185. Wang, N.; Hao, H.S.; Li, C.Y.; Zhao, Y.H.; Wang, H.Y.; Yan, C.L.; Du, W.H.; Wang, D.; Liu, Y.; Pang, Y.W.; et al. Calcium ion regulation by BAPTA-AM and ruthenium red improved the fertilisation capacity and developmental ability of vitrified bovine oocytes. Sci. Rep. 2017, 7, 10652. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  186. Takahashi, T.; Hammett, M.F.; Cho, M.S. Multifaceted freezing injury in human polymorphonuclear cells at high subfreezing temperatures. Cryobiology 1985, 22, 215–236. [Google Scholar] [CrossRef]
  187. Zhang, F.; Zhang, Z.Y.; Cai, M.D.; Li, X.X.; Li, Y.H.; Lei, Y.; Yu, X.L. Effect of vitrification temperature and cryoprotectant concentrations on the mRNA transcriptome of bovine mature oocytes after vitrifying at immature stage. Theriogenology 2020, 148, 225–235. [Google Scholar] [CrossRef] [PubMed]
  188. Daddangadi, A.; Uppangala, S.; Kalthur, G.; Talevi, R.; Adiga, S.K. Germinal stage vitrification is superior to MII stage vitrification in prepubertal mouse oocytes. Cryobiology 2020, 93, 49–55. [Google Scholar] [CrossRef]
  189. Liu, M.H.; Zhou, W.H.; Chu, D.P.; Fu, L.; Sha, W.; Li, Y. Ultrastructural changes and methylation of human oocytes vitrified at the germinal vesicle stage and matured in vitro after thawing. Gynecol. Obstet. Investig. 2017, 82, 252–261. [Google Scholar] [CrossRef] [PubMed]
  190. Chen, C.; Han, S.; Liu, W.; Wang, Y.; Huang, G. Effect of vitrification on mitochondrial membrane potential in human metaphase II oocytes. J. Assist. Reprod. Genet. 2012, 29, 1045–1050. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  191. Larman, M.G.; Sheehan, C.B.; Gardner, D.K. Calcium-free vitrification reduces cryoprotectant-induced zona pellucida hardening and increases fertilization rates in mouse oocytes. Reproduction 2006, 131, 53–61. [Google Scholar] [CrossRef] [PubMed]
  192. Larman, M.G.; Katz-Jaffe, M.G.; Sheehan, C.B.; Gardner, D.K. 1,2-propanediol and the type of cryopreservation procedure adversely affect mouse oocyte physiology. Hum. Reprod. 2007, 22, 250–259. [Google Scholar] [CrossRef] [PubMed]
  193. Takahashi, T.; Igarashi, H.; Doshida, M.; Takahashi, K.; Nakahara, K.; Tezuka, N.; Kurachi, H. Lowering intracellular and extracellular calcium contents prevents cytotoxic effects of ethylene glycol-based vitrification solution in unfertilized mouse oocytes. Mol. Reprod. Dev. 2004, 68, 250–258. [Google Scholar] [CrossRef]
  194. Marques, C.C.; Santos-Silva, C.; Rodrigues, C.; Matos, J.E.; Moura, T.; Baptista, M.C.; Horta, A.E.M.; Bessa, R.J.B.; Alves, S.P.; Soveral, G.; et al. Bovine oocyte membrane permeability and cryosurvival: Effects of different cryoprotectants and calcium in the vitrification media. Cryobiology 2018, 81, 4–11. [Google Scholar] [CrossRef] [PubMed]
  195. Budd, S.L.; Nicholls, D.G. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 1996, 67, 2282–2291. [Google Scholar] [CrossRef]
  196. Galluzzi, L.; Morselli, E.; Kepp, O.; Kroemer, G. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim. Biophys. Acta 2009, 1787, 402–413. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  197. Elrod, J.W.; Wong, R.; Mishra, S.; Vagnozzi, R.J.; Sakthievel, B.; Goonasekera, S.A.; Karch, J.; Gabel, S.; Farber, J.; Force, T.; et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Investig. 2010, 120, 3680–3687. [Google Scholar] [CrossRef] [PubMed]
  198. Hou, Y.; Ouyang, X.; Wan, R.; Cheng, H.; Mattson, M.P.; Cheng, A. Mitochondrial superoxide production negatively regulates neural progenitor proliferation and cerebral cortical development. Stem Cells 2012, 30, 2535–2547. [Google Scholar] [CrossRef] [Green Version]
  199. Ozil, J.P.; Huneau, D. Activation of rabbit oocytes: The impact of the Ca2+ signal regime on development. Development 2001, 128, 917–928. [Google Scholar] [PubMed]
  200. Ducibella, T.; Huneau, D.; Angelichio, E.; Xu, Z.; Schultz, R.M.; Kopf, G.S.; Fissore, R.; Madoux, S.; Ozil, J.P. Egg-to-embryo transition is driven by differential responses to Ca(2+) oscillation number. Dev. Biol. 2002, 250, 280–291. [Google Scholar] [CrossRef] [PubMed]
  201. Ozil, J.P.; Banrezes, B.; Toth, S.; Pan, H.; Schultz, R.M. Ca2+oscillatory pattern in fertilized mouse eggs affects gene expression and development to term. Dev. Biol. 2006, 300, 534–544. [Google Scholar] [CrossRef] [Green Version]
  202. Borini, A.; Sciajno, R.; Bianchi, V.; Sereni, E.; Flamigni, C.; Coticchio, G. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum. Reprod. 2006, 21, 512–517. [Google Scholar] [CrossRef] [Green Version]
  203. La Sala, G.B.; Nicoli, A.; Villani, M.T.; Pescarini, M.; Gallinelli, A.; Blickstein, I. Outcome of 518 salvage oocyte-cryopreservation cycles performed as a routine procedure in an in vitro fertilization program. Fertil. Steril. 2006, 86, 1423–1427. [Google Scholar] [CrossRef]
  204. Levi Setti, P.E.; Albani, E.; Novara, P.V.; Cesana, A.; Morreale, G. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum. Reprod. 2006, 21, 370–375. [Google Scholar] [CrossRef] [Green Version]
  205. Gualtieri, R.; Mollo, V.; Barbato, V.; Fiorentino, I.; Iaccarino, M.; Talevi, R. Ultrastructure and intracellular calcium response during activation in vitrified and slow-frozen human oocytes. Hum. Reprod. 2011, 26, 2452–2460. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  206. Kim, B.Y.; Yoon, S.Y.; Cha, S.K.; Kwak, K.H.; Fissore, R.A.; Parys, J.B.; Yoon, T.K.; Lee, D.R. Alterations in calcium oscillatory activity in vitrified mouse eggs impact on egg quality and subsequent embryonic development. Pflug. Arch. 2011, 461, 515–526. [Google Scholar] [CrossRef] [PubMed]
  207. Bonte, D.; Thys, V.; De Sutter, P.; Boel, A.; Leybaert, L.; Heindryckx, B. Vitrification negatively affects the Ca2+-releasing and activation potential of mouse oocytes, but vitrified oocytes are potentially useful for diagnostic purposes. Reprod. Biomed. Online 2020, 40, 13–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  208. Dai, J.; Wu, C.; Muneri, C.W.; Niu, Y.; Zhang, S.; Rui, R.; Zhang, D. Changes in mitochondrial function in porcine vitrified MII-stage oocytes and their impacts on apoptosis and developmental ability. Cryobiology 2015, 71, 291–298. [Google Scholar] [CrossRef]
  209. Dai, J.J.; Yang, J.H.; Zhang, S.S.; Niu, Y.F.; Chen, Y.N.; Wu, C.F.; Zhang, D.F. Partial recovery of mitochondrial function of vitrified porcine MII stage oocytes during post-thaw incubation. Cryo Lett. 2018, 39, 39–44. [Google Scholar]
  210. Karlsson, J.O.; Eroglu, A.; Toth, T.L.; Cravalho, E.G.; Toner, M. Fertilization and development of mouse oocytes cryopreserved using a theoretically optimized protocol. Hum. Reprod. 1996, 11, 1296–1305. [Google Scholar] [CrossRef] [Green Version]
  211. Oktay, K.; Cil, A.P.; Bang, H. Efficiency of oocyte cryopreservation: A meta-analysis. Fertil Steril. 2006, 86, 70–80. [Google Scholar] [CrossRef] [PubMed]
  212. Eroglu, B.; Szurek, E.A.; Schall, P.; Latham, K.E.; Eroglu, A. Probing lasting cryoinjuries to oocyte-embryo transcriptome. PLoS ONE 2020, 15, e0231108. [Google Scholar] [CrossRef] [Green Version]
  213. Ruihuan, G.; Zhichao, L.; Song, G.; Jing, F.; Yijuan, S.; Xiaoxi, S. Oocyte vitrification temporarily turns on oxidation-reduction process genes in mouse preimplantation embryos. Reprod. Sci. 2020. Online ahead of print. [Google Scholar] [CrossRef] [PubMed]
  214. Arnanz, A.; De Munck, N.; Bayram, A.; El-Damen, A.; Abdalla, A.; ElKhatib, I.; Melado, L.; Lawrenz, B.; Fatemi, H.M. Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: A sibling oocyte study. J. Assist. Reprod. Genet. 2020, 37, 1387–1397. [Google Scholar] [CrossRef]
  215. Dai, J.J.; Niu, Y.F.; Wu, C.F.; Zhang, S.H.; Zhang, D.F. Both death receptor and mitochondria mediated apoptotic pathways participated the occurrence of apoptosis in porcine vitrified mii stage oocytes. Cryo Lett. 2016, 37, 129–136. [Google Scholar]
  216. Pan, B.; Yang, H.; Wu, Z.; Qazi, I.H.; Liu, G.; Han, H.; Meng, Q.; Zhou, G. Melatonin Improves Parthenogenetic Development of Vitrified–Warmed Mouse Oocytes Potentially by Promoting G1/S Cell Cycle Progression. Int. J. Mol. Sci. 2018, 19, 4029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  217. Mukunoki, A.; Takeo, T.; Nakagata, N. N-acetyl cysteine restores the fertility of vitrified-warmed mouse oocytes derived through ultrasuperovulation. PLoS ONE 2019, 14, e0224087. [Google Scholar] [CrossRef] [PubMed]
  218. Borjizadeh, A.; Ahmadi, H.; Daneshi, E.; Roshani, D.; Fathi, F.; Abdi, M.; Nasseri, S.; Abouzaripour, M. The effect of adding rosmarinic and ascorbic acids to vitrification media on fertilization rate of the mice oocyte: An experimental study. Int. J. Reprod. Biomed. 2019, 17, 195–200. [Google Scholar] [CrossRef] [PubMed]
  219. Yashiro, I.; Tagiri, M.; Ogawa, H.; Tashima, K.; Takashima, S.; Hara, H.; Hirabayashi, M.; Hochi, S. High revivability of vitrified-warmed bovine mature oocytes after recovery culture with α-tocopherol. Reproduction 2015, 149, 347–355. [Google Scholar] [CrossRef] [Green Version]
  220. Moawad, A.R.; Tan, S.L.; Xu, B.; Chen, H.Y.; Taketo, T. L-carnitine supplementation during vitrification of mouse oocytes at the germinal vesicle stage improves preimplantation development following maturation and fertilization in vitro. Biol. Reprod. 2013, 88, 104. [Google Scholar] [CrossRef] [PubMed]
  221. Trapphoff, T.; Heiligentag, M.; Simon, J.; Staubach, N.; Seidel, T.; Otte, K.; Fröhlich, T.; Arnold, G.J.; Eichenlaub-Ritter, U. Improved cryotolerance and developmental potential of in vitro and in vivo matured mouse oocytes by supplementing with a glutathione donor prior to vitrification. Mol. Hum. Reprod. 2016, 22, 867–881. [Google Scholar]
  222. García-Martínez, T.; Vendrell-Flotats, M.; Martínez-Rodero, I.; Ordóñez-León, E.A.; Álvarez-Rodríguez, M.; López-Béjar, M.; Yeste, M.; Mogas, T. Glutathione ethyl ester protects in vitro-maturing bovine oocytes against oxidative stress induced by subsequent vitrification/warming. Int. J. Mol. Sci. 2020, 21, 7547. [Google Scholar] [CrossRef]
  223. Li, Z.; Gu, R.; Lu, X.; Zhao, S.; Feng, Y.; Sun, Y. Preincubation with glutathione ethyl ester improves the developmental competence of vitrified mouse oocytes. J. Assist. Reprod. Genet. 2018, 35, 1169–1178. [Google Scholar] [CrossRef] [PubMed]
  224. Rashedi, A.S.; de Roo, S.F.; Ataman, L.M.; Edmonds, M.E.; Silva, A.A.; Scarella, A.; Horbaczewska, A.; Anazodo, A.; Arvas, A.; Ramalho de Carvalho, B.; et al. Survey of fertility preservation options available to patients with cancer around the globe. JCO Glob. Oncol. 2020, 6, JGO.2016.008144. [Google Scholar] [CrossRef]
  225. Eyden, B.; Radford, J.; Shalet, S.M.; Thomas, N.; Brison, D.R.; Lieberman, B.A. Ultrastructural preservation of ovarian cortical tissue cryopreserved in dimethylsulfoxide for subsequent transplantation into young female cancer patients. Ultrastruct. Pathol. 2004, 28, 239–245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  226. Gook, D.A.; Edgar, D.H.; Stern, C. The effects of cryopreservation regimens on the morphology of human ovarian tissue. Mol. Cell. Endocrinol. 2000, 169, 99–103. [Google Scholar] [CrossRef]
  227. Salehnia, M.; Abbasian, M.E.; Rezazadeh, V.M. Ultrastructure of follicles after vitrification of mouse ovarian tissue. Fertil. Steril. 2002, 78, 644–645. [Google Scholar] [CrossRef]
  228. Talevi, R.; Barbato, V.; Mollo, V.; Fiorentino, I.; De Stefano, C.; Guarino, F.M.; Gualtieri, R. Replacement of sodium with choline in slow-cooling media improves human ovarian tissue cryopreservation. Reprod. Biomed. Online 2013, 27, 381–389. [Google Scholar] [CrossRef] [Green Version]
  229. Fabbri, R.; Vicenti, R.; Macciocca, M.; Martino, N.A.; Dell’Aquila, M.E.; Pasquinelli, G.; Morselli-Labate, A.M.; Seracchioli, R.; Paradisi, R. Morphological, ultrastructural and functional imaging of frozen/thawed and vitrified/warmed human ovarian tissue retrieved from oncological patients. Hum. Reprod. 2016, 31, 1838–1849. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  230. Talevi, R.; Barbato, V.; Fiorentino, I.; Braun, S.; De Stefano, C.; Ferraro, R.; Sudhakaran, S.; Gualtieri, R. Successful slush nitrogen vitrification of human ovarian tissue. Fertil. Steril. 2016, 105, 1523–1531.e1. [Google Scholar] [CrossRef] [Green Version]
  231. Barbato, V.; Gualtieri, R.; Capriglione, T.; Pallotta, M.M.; Braun, S.; Di Nardo, M.; Costanzo, V.; Ferraro, R.; Catapano, G.; Talevi, R. Slush nitrogen vitrification of human ovarian tissue does not alter gene expression and improves follicle health and progression in long-term in vitro culture. Fertil. Steril. 2018, 110, 1356–1366. [Google Scholar] [CrossRef]
  232. Mathias, F.J.; D’Souza, F.; Uppangala, S.; Salian, S.R.; Kalthur, G.; Adiga, S.K. Ovarian tissue vitrification is more efficient than slow freezing in protecting oocyte and granulosa cell DNA integrity. Syst. Biol. Reprod. Med. 2014, 60, 317–322. [Google Scholar] [CrossRef] [PubMed]
  233. Salehnia, M.; Töhönen, V.; Zavareh, S.; Inzunza, J. Does cryopreservation of ovarian tissue affect the distribution and function of germinal vesicle oocytes mitochondria? Biomed. Res. Int. 2013, 2013, 489032. [Google Scholar] [CrossRef]
  234. Sun, T.C.; Liu, X.C.; Yang, S.H.; Song, L.L.; Zhou, S.J.; Deng, S.L.; Tian, L.; Cheng, L.Y. Melatonin inhibits oxidative stress and apoptosis in cryopreserved ovarian tissues via Nrf2/HO-1 signaling pathway. Front. Mol. Biosci. 2020, 7, 163. [Google Scholar] [CrossRef]
  235. Arkoun, B.; Galas, L.; Dumont, L.; Rives, A.; Saulnier, J.; Delessard, M.; Rondanino, C.; Rives, N. Vitamin E but not GSH decreases reactive oxygen species accumulation and enhances sperm production during in vitro maturation of frozen-thawed prepubertal mouse testicular tissue. Int. J. Mol. Sci. 2019, 20, 5380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  236. Zhang, X.G.; Wang, Y.H.; Han, C.; Hu, S.; Wang, L.Q.; Hu, J.H. Effects of trehalose supplementation on cell viability and oxidative stress variables in frozen-thawed bovine calf testicular tissue. Cryobiology 2015, 70, 246–252. [Google Scholar] [CrossRef] [PubMed]
  237. Moubasher, A.E.; Taha, E.A.; Younis, A.; Fakhry, M.E.; Morsy, H. Testicular tissue oxidative stress in azoospermic patients: Effect of cryopreservation. Andrologia 2020, 52, e13817. [Google Scholar] [CrossRef] [PubMed]
  238. Keros, V.; Rosenlund, B.; Hultenby, K.; Aghajanova, L.; Levkov, L.; Hovatta, O. Optimizing cryopreservation of human testicular tissue: Comparison of protocols with glycerol, propanediol and dimethylsulphoxide as cryoprotectants. Hum. Reprod. 2005, 20, 1676–1687. [Google Scholar] [CrossRef] [Green Version]
  239. Ha, S.J.; Kim, B.G.; Lee, Y.A.; Kim, Y.H.; Kim, B.J.; Jung, S.E.; Pang, M.G.; Ryu, B.Y. Effect of antioxidants and apoptosis inhibitors on cryopreservation of murine germ cells enriched for spermatogonial stem cells. PLoS ONE 2016, 11, e0161372. [Google Scholar] [CrossRef] [Green Version]
  240. Fabbri, R.; Pasquinelli, G.; Bracone, G.; Orrico, C.; Paradisi, R.; Seraccioli, R.; Venturoli, S. Fetal calf serum versus human serum: Ultrastructural evaluation of protein support influence on human ovarian tissue cryopreservation. Ultrastruct. Pathol. 2006, 30, 253–260. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Roles of sperm mitochondria in health. Production of ATP and ROS by sperm mitochondria is involved in several sperm functions. Modified from https://www.vecteezy.com/vector-art/1434164-human-sperm-or-spermatozoa-cell-structure (accessed on 28 December 2020).
Figure 1. Roles of sperm mitochondria in health. Production of ATP and ROS by sperm mitochondria is involved in several sperm functions. Modified from https://www.vecteezy.com/vector-art/1434164-human-sperm-or-spermatozoa-cell-structure (accessed on 28 December 2020).
Antioxidants 10 00337 g001
Figure 2. Possible mechanisms of sperm mitochondrial dysfunction associated with cryopreservation. Exposure to permeant cryoprotectants cause intracellular Ca2+ increase. Prolonged openings of mPTP due to Ca2+ overload trigger ROS and Ca2+ release, loss of ΔΨm, decreased ATP content, and release of Cyt C. Such events may culminate in DNA damage and apoptosis. Depending on the extent of mitochondrial damage, the sperm can die or survive to cryopreservation. Oocytes fertilized by survived, DNA damaged sperm, could hesitate into a compromised embryo development. PROH, propanediol; EG, ethylene glycol; DMSO, dimethyl sulfoxide. Modified from https://www.vecteezy.com/vector-art/1434164-human-sperm-or-spermatozoa-cell-structure (accessed on 28 December 2020).
Figure 2. Possible mechanisms of sperm mitochondrial dysfunction associated with cryopreservation. Exposure to permeant cryoprotectants cause intracellular Ca2+ increase. Prolonged openings of mPTP due to Ca2+ overload trigger ROS and Ca2+ release, loss of ΔΨm, decreased ATP content, and release of Cyt C. Such events may culminate in DNA damage and apoptosis. Depending on the extent of mitochondrial damage, the sperm can die or survive to cryopreservation. Oocytes fertilized by survived, DNA damaged sperm, could hesitate into a compromised embryo development. PROH, propanediol; EG, ethylene glycol; DMSO, dimethyl sulfoxide. Modified from https://www.vecteezy.com/vector-art/1434164-human-sperm-or-spermatozoa-cell-structure (accessed on 28 December 2020).
Antioxidants 10 00337 g002
Figure 3. Roles of oocyte mitochondria in health. Production of ATP and ROS by oocyte mitochondria is involved in fertilization and embryo development. Upon gamete fusion, diffusion of a sperm soluble factor (SSF) into the oocyte cytosol generates IP3 which binds endoplasmic reticulum (ER) IP3 receptors (IP3R) causing cytosolic Ca2+ oscillations. Cytosolic Ca2+ rise drives numerous events among which the exocytosis of cortical granules (CG) and the consequent hardening and polyspermy block of the zona pellucida (ZP). Ca2+ potentiates the mitochondrial production of ATP which is needed for Ca2+ reuptake into the endoplasmic reticulum through Ca2+ ATPase allowing the recovery of cytosolic Ca2+ levels after each transient. Evidence in oocytes from different species indicates that sperm-induced Ca2+ rise triggers a release of ROS from mitochondria which is required for embryo development.
Figure 3. Roles of oocyte mitochondria in health. Production of ATP and ROS by oocyte mitochondria is involved in fertilization and embryo development. Upon gamete fusion, diffusion of a sperm soluble factor (SSF) into the oocyte cytosol generates IP3 which binds endoplasmic reticulum (ER) IP3 receptors (IP3R) causing cytosolic Ca2+ oscillations. Cytosolic Ca2+ rise drives numerous events among which the exocytosis of cortical granules (CG) and the consequent hardening and polyspermy block of the zona pellucida (ZP). Ca2+ potentiates the mitochondrial production of ATP which is needed for Ca2+ reuptake into the endoplasmic reticulum through Ca2+ ATPase allowing the recovery of cytosolic Ca2+ levels after each transient. Evidence in oocytes from different species indicates that sperm-induced Ca2+ rise triggers a release of ROS from mitochondria which is required for embryo development.
Antioxidants 10 00337 g003
Figure 4. Possible mechanisms of oocyte mitochondrial disfunctions associated with cryopreservation. Exposure to permeant cryoprotectants causes intracellular Ca2+ increase. Propanediol (PROH) and ethylene glycol (EG) vehiculate external Ca2+, whereas dimethyl sulfoxide (DMSO) triggers Ca2+ release from the endoplasmic reticulum (ER). Premature Ca2+ rise causes partial cortical granule (CG) exocytosis and zona pellucida (ZP) hardening. Prolonged openings of mPTP due to Ca2+ overload trigger ROS and Ca2+ release, loss of ΔΨm, decreased ATP content, and release of Cyt C. Such events may culminate in DNA damage and apoptosis. The extent of mitochondrial injury in cryopreserved oocytes determines whether the oocyte dies or survives. Substantial mitochondrial damage might lead to altered Ca2+ and ROS signaling at fertilization, and compromised embryo development. Inset, intact (green asterisk) and damaged (red asterisk) mitochondria in a human oocyte cryopreserved through slow cooling (bar = 0.5 μm).
Figure 4. Possible mechanisms of oocyte mitochondrial disfunctions associated with cryopreservation. Exposure to permeant cryoprotectants causes intracellular Ca2+ increase. Propanediol (PROH) and ethylene glycol (EG) vehiculate external Ca2+, whereas dimethyl sulfoxide (DMSO) triggers Ca2+ release from the endoplasmic reticulum (ER). Premature Ca2+ rise causes partial cortical granule (CG) exocytosis and zona pellucida (ZP) hardening. Prolonged openings of mPTP due to Ca2+ overload trigger ROS and Ca2+ release, loss of ΔΨm, decreased ATP content, and release of Cyt C. Such events may culminate in DNA damage and apoptosis. The extent of mitochondrial injury in cryopreserved oocytes determines whether the oocyte dies or survives. Substantial mitochondrial damage might lead to altered Ca2+ and ROS signaling at fertilization, and compromised embryo development. Inset, intact (green asterisk) and damaged (red asterisk) mitochondria in a human oocyte cryopreserved through slow cooling (bar = 0.5 μm).
Antioxidants 10 00337 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gualtieri, R.; Kalthur, G.; Barbato, V.; Di Nardo, M.; Adiga, S.K.; Talevi, R. Mitochondrial Dysfunction and Oxidative Stress Caused by Cryopreservation in Reproductive Cells. Antioxidants 2021, 10, 337. https://doi.org/10.3390/antiox10030337

AMA Style

Gualtieri R, Kalthur G, Barbato V, Di Nardo M, Adiga SK, Talevi R. Mitochondrial Dysfunction and Oxidative Stress Caused by Cryopreservation in Reproductive Cells. Antioxidants. 2021; 10(3):337. https://doi.org/10.3390/antiox10030337

Chicago/Turabian Style

Gualtieri, Roberto, Guruprasad Kalthur, Vincenza Barbato, Maddalena Di Nardo, Satish Kumar Adiga, and Riccardo Talevi. 2021. "Mitochondrial Dysfunction and Oxidative Stress Caused by Cryopreservation in Reproductive Cells" Antioxidants 10, no. 3: 337. https://doi.org/10.3390/antiox10030337

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop